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ABSTRACT OF DISSERTATION 
 
 
 
DIFFERENTIAL INNATE IMMUNE RESPONSES CORRELATE WITH THE 
CONTRASTING PATHOGENICITY OF THE EQUINE H7N7 INFLUENZA VIRUS 
DEMONSTRATED IN HORSES AND BALB/C MICE  
 
Equine influenza virus causes a mild, self-limiting upper respiratory disease in its natural 
host. In stark contrast, equine influenza viruses of the H7N7 subtype produce lethal 
infection in BALB/c mice. This dissertation explored the mechanism underlying the 
differential pathogenicity of the equine H7N7 influenza virus observed in horses and 
BALB/c mice. Initially, a comparative study of the pathogenesis was conducted in 
BALB/c mice inoculated intranasally with a representative isolate of either H7N7 or 
H3N8 subtype equine influenza virus. All H3N8 virus-infected mice survived the 
infection whereas 100% mortality was documented for the mice receiving the H7N7 virus 
by day 8 post infection. Both viruses replicated to a similar degree in the lungs at the 
early stages of infection. However, after day 2 post infection until the death of the mice, 
the pulmonary viral loads of the H7N7 group were significantly higher than those of the 
control, whereas the H3N8 virus was eventually eradicated from the mice at day 7 p.i. 
Correspondingly, a vigorous pro-inflammatory cytokine response in the lung was induced 
by the H7N7 virus but not the H3N8 virus, which reflected a desperate attempt by the 
host immune responses to restrain the overwhelming infection. The H7N7 virus was 
poorly sensitive to the innate immune containment, resulting in a significant higher 
cumulative mortality rate than that of the control virus in chicken embryos aged 9 days 
and older. On the contrary, in horses, replication of the paired viruses was completely 
cleared by the host immune responses at day 7 p.i. and the infections produced an acute 
yet non-lethal illness, albeit the H3N8 virus induced generally more pronounced clinical 
manifestations than the H7N7 virus. The clinical severity correlated to the difference in 
cytokine-inducing capacity between the two viruses in horses, as evidenced by the 
finding that the H3N8 virus triggered significantly higher levels of gene transcription of 
multiple key inflammatory cytokines in the circulation than those seen for the H7N7 
virus. In addition, equine peripheral monocyte-derived macrophages were found to be a 
target of equine influenza virus and can support the productive replication of the virus in 
vitro.  
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CHAPTER ONE 
Introduction and Literature Review 
INTRODUCTION 
 
The Orthomyxoviridae are a family of segmented, single-stranded negative sense 
RNA viruses that consists of the five genera: Influenzavirus A, Influenzavirus B, 
Influenzavirus C, Thogatovirus and Isavirus. Infectious salmon anemia virus is the only 
known virus of the genus Isavirus and appears to cause disease in farmed Atlantic 
salmon. The genus Thogotovirus is currently composed of two species: Thogoto virus 
and Dhori virus. They are tick-borne viruses that occasionally infect mammals, including 
humans [1]. Influenza A, B and C viruses are distinguished on the basis of the antigenic 
differences in their internal nucleocapsid (NP) and matrix (M) proteins. Influenza C virus 
infects humans and swine, while Influenza B virus can infect humans and seals. Influenza 
A virus, however, causes highly contagious disease in a wide range of mammalian and 
avian species, including humans, pigs, horses, cats, dogs, sea mammals, and domestic as 
well as wild birds [2]. Wild waterfowl play a critical role in the epidemiology of 
influenza, as these birds function as a vast reservoir of all influenza A viruses in nature, 
from which viruses can be transmitted to other animals and humans [3]. Influenza A 
viruses are divided into subtypes based on the antibody response to their surface HA and 
NA proteins. To date, 16 HA and 9 NA subtypes have been identified among influenza A 
viruses [4]. Influenza is one of the major respiratory infections of humans, and is 
responsible for pandemics and annual epidemics in the world. Historically, there have 
been four devastating human influenza pandemics since the last century. The 1918-1919 
pandemic, the famous “Spanish flu”, was the most severe, and killed an estimated 20 to 
40 million people globally [5]. Phylogenetic analyses indicated that the 1918 strain was 
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an H1N1 subtype virus from an avian ancestor [6]. In 1957, the H2N2 subtype emerged 
causing a less devastating pandemic for humans. The third pandemic of influenza virus 
occurred during 1968-1969 and involved the H3N2 subtype [7]. The latest pandemic 
caused by a novel swine-origin influenza A (H1N1) virus emerged in early 2009 [8]. 
H1N1 and H3N2 and reassortants are currently circulating in the human population 
causing annual seasonal influenza [9]. Recent outbreaks of avian influenza H5N1, H7N7 
and H9N2 virus infections in humans raise concern about the next potential human 
pandemic. These avian viruses were transmitted directly from domestic poultry to 
humans without an intermediate host [10]. Fortunately, these viruses have not acquired 
the ability to spread among humans [11]. To date, only the H7N7 and H3N8 subtype 
viruses have been responsible for influenza in equine populations. Equine influenza is 
one of the major infectious respiratory diseases with economic significance in equines. 
Annual outbreaks have an effect on horse racing, performance and breeding over the 
world [12]. The general outline of this dissertation begins with a literature review of 
current knowledge on equine influenza, the biology of influenza A viruses, the 
pathogenesis of virus in avian and mammals, and the immune responses to the influenza 
A virus infection, followed by research objectives in the end. 
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LITERATURE REVIEW 
 
Section I: Equine Influenza 
 
          An influenza-like respiratory disease has been recognized in horses for centuries, 
probably as long as in humans [3, 13]. However, it was not until 1956 that influenza A 
virus was first officially identified as the etiological agent of equine respiratory disease 
[14]. The original isolate collected from an infected horse during that outbreak in Central 
Europe was subtyped as H7N7. Serological evidence suggested that this virus subtype 
had circulated among horse populations in Europe and the Americas even before 1956 
[15-16].  In 1963, a new equine influenza virus of different antigenic subtype (H3N8) 
appeared during a major epidemic in the USA [13]. Following that isolation, these two 
antigenically distinct subtypes of equine influenza viruses cocirculated in equine 
population and in some outbreaks simultaneous isolation of both subtype viruses 
occurred [17]. 
Cocirculation of two distinct subtypes provides the opportunity for genetic 
exchange between both subtypes in nature. Phylogenetic analysis of equine influenza 
isolates indicated that they probably emerged from avian gene pool [18-19] and the 
internal genes (NP, PA, PB1, PB2, M and NS) of H7N7 viruses isolated during 1970’s 
derived from H3N8 viruses by genetic reassortment [18, 20-21]. The last confirmed 
outbreak of equine influenza caused by an H7N7 subtype virus was in 1979 [22]. Since 
then the H7N7 subtype virus has not been isolated from horses. However, serological 
evidence indicated that this virus subtype may still have been in circulation as late as 
1991 in some parts of the world [23]. In contrast, the H3N8 subtype virus remains 
prevalent among horses causing annual epidemics worldwide.  
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 The reason(s) that the equine H7N7 subtype virus disappeared from equine 
populations remains unknown. It is presumed that the H7N7 virus was under negative 
selection pressure during evolution. Interestingly, this is not a unique scenario. In 1989, 
an H3N8 influenza virus from birds was introduced into horses in Northeastern China 
and resulted in up to 20% mortality in some herds [19]. However, this particular strain 
did not spread beyond or persist in China beyond 1990 [24].  
 
Section II: The Biology of Influenza A Virus 
 
1. Virion Architecture and Genome 
Influenza A viruses belong to the family of Orthomyxoviridae. The viruses have 
eight separate single-stranded, negative sense RNA segments enclosed in a lipid envelope 
[1]. The virion is 80 to 120 nm in diameter and has a regular spherical appearance if 
propagated in eggs or cell culture. In contrast, influenza A viruses exhibit pleomorphism 
on initial isolation from humans or animals [25-26]. There are two types of virus encoded 
surface glycoproteins which protrude like spikes from the lipid envelope: rod-shaped 
hemagglutinin (HA) and mushroom-shaped neuraminidase (NA). The small quantities of 
M2 protein function as a membrane-channel protein in the envelope. The M1 protein,  the 
most abundant protein in the virion, underlies the envelope and interacts with the 
ribonucleoproteins [27]. The eight separate RNPs have the appearance of flexible rods. 
Each RNP consists of a RNA segment encapsidated by several nucleocapsid protein (NP) 
molecules. Associated with the end of each RNP are the three viral polymerase proteins 
PB1, PB2 and PA [28].   
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2.  Viral Proteins and Their Functions 
Hemagglutinin (HA)  
The surface HA glycoprotein, encoded by the fourth largest RNA segment, is a 
homotrimeric spike of noncovalently linked monomers that are synthesized in the rough 
endoplasmic reticulum of infected host cells [29]. The HA molecule is produced as an 
uncleaved single precursor polypeptide, HA0, which is cotranslationally modified by the 
addition of oligosaccharide chains. The next processing step is the proteolytic cleavage of 
the HA0 into two disulfide-linked subunits referred to as HA1 and HA2. The glycine-rich 
membrane fusion peptide is located at the amino acid terminus of the HA2 subunit [30]. 
The cleavage step is a prerequisite for the virus to be infectious and is accomplished by 
host proteases. Depending on the HA structural property of a virus strain, cleavage 
happens either by ubiquitously distributed proteases such as furin [31-32] or by tissue-
specific proteases such as trypsin [33]. Therefore, HA cleavability is a crucial 
determinant of viral pathogenicity [34]. As a major surface glycoprotein of influenza A 
virus, HA has two primary functions: (1) it binds to sialic acid containing receptors on 
cell surfaces during viral attachment, and (2) mediates fusion between the endocytic 
vesicle and viral membranes during penetration, enabling the viral genome to be released 
into the cytoplasm. In addition, the HA molecule is the major target for antibody 
neutralization, and a mutation in HA may allow the virus to escape neutralizing 
antibodies by antigenic drift [35]. 
            Neuraminidase (NA) 
NA is the second surface glycoprotein of the virion. In parallel with HA, NA is 
also a major antigenic determinant that undergoes antigenic variation in response to host 
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immune pressure. The function of NA includes the removal of sialic acid residues from 
viral glycoproteins or glycolipid receptors on the host cell surface, thus allowing the 
release of progeny virus from the infected cells [36]. NA also promotes virus invasion of 
the epithelial cells during virus entry [37]. Additionally, NA may play a role in influenza 
virus pathogenesis such as by induction of apoptosis [38], and activation of TGF-β 
expression in mice and cell cultures [39].  
Matrix (M1) and M2 proteins 
The seventh RNA segment encodes two proteins in overlapping reading frames 
derived by alternative splicing. M1 is a structural protein underlying the lipid envelope 
and constitutes the most abundant protein of the virion. The M1 interacts with the 
cytoplasmic tails of HA, NA and M2 proteins as well as RNP structures and is believed 
to play an important role in assembly and budding of progeny virus [40]. M2 is an 
integral membrane protein, and functions as a proton ion channel to allow acidification of 
the interior of the virion during virus entry [41]. 
Nucleoprotein (NP) 
NP is the second most abundant protein of the virion. After synthesis and 
posttranslational phosphorylation in the cytoplasm, NP is then transported into the 
nucleus of infected cells, where it binds to newly synthesized viral RNA, forming the 
ribonucleoprotein (RNP) complexes [42-43]. NP is also the major target of cytotoxic T 
lymphocytes that non-specifically cross-react with NP of all influenza virus subtypes 
[44]. 
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Polymerase proteins 
The three largest RNA segments encode the PB1, PB2 and PA proteins 
respectively. The proteins are named based on their properties in isolectric focusing gel, 
two proteins are basic (PB1 and PB2) and one acidic (PA). These proteins form a 
complex that provides RNA-dependent RNA polymerase activity for the virus [45-46]. 
PB2 recognizes and binds the 5’ cap structure of host cellular mRNA that is used for the 
priming of viral mRNA transcription. PB1 serves as the elongation protein for viral 
mRNA and genomic RNA synthesis [47-48]. The recently identified PB1-F2 protein, 
which is encoded by an alternative reading frame of PB1, has been found to localize to 
the inner mitochondria of infected cells. This novel 87-residue peptide disrupts 
mitochondrial membrane integrity which leads to apoptotic cell death [49-50]. The 
precise role of PA remains unknown, although there is evidence for its possible role in 
both viral transcription and replication [51]. 
Non-structural (NS) proteins 
RNA segment eight encodes two non-structural proteins, NS1 and NS2, where the 
NS2 mRNA is derived from splicing of the NS1 mRNA [52]. Although the NS1 is 
abundantly present in influenza virus-infected cells, it is not incorporated into the 
progeny virion [53]. NS1 is a multifunctional protein that plays an important role in the 
influenza pathogenesis. So far, many functions have been associated with NS1 protein, 
including inhibiting cellular mRNA splicing [54], inhibiting nuclear export of 
polyadenylated cellular mRNAs [55], directing preferential translation of viral mRNAs 
by binding to the 5’ UTR of the viral mRNAs [56] and binding to dsRNA to block the 
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activation of dsRNA-activated protein kinase (PKR) [57]. NS2 has been demonstrated to 
facilitate the export of viral RNPs from the nucleus to the cytoplasm [58]. 
3. Replication Cycle of Influenza A Virus 
Virus replication consists of three major steps: (1) viral attachment, entry and 
uncoating (2) viral gene expression and replication and (3) virus assembly, budding and 
release. (1) Viral attachment involves the binding of HA to sialic acid-containing 
receptors on the host cell surface [59]. Upon binding, the virus enters the cell by receptor 
mediated endocytosis. Cellular proton pumps gradually acidify the endosomal 
compartments and induce a conformational change of the HA, which leads to the 
exposure of the fusion peptide and ultimately to the fusion of the viral and cellular 
membranes [60-61]. The M2 ion channel protein allows the flow of ions from the 
endosome to the virion interior, facilitating the dissociation of the vRNP from M1 and 
then release into the cytoplasm of the cell as the uncoating process is completed [62]. (2) 
The RNP segments are then transported into the nucleus where transcription and 
replication take place [63]. Initiation of transcription of viral mRNA requires priming 
with capped RNA primers from the 5’ end of cellular mRNAs. The process of cap 
recognition is mediated by the viral PB2 protein, while the PB1 protein functions as the 
endonuclease and polymerase [64-66]. Transcribed mRNAs are then exported to the 
cytoplasm for translation by the host translation machinery. Replication of the viral 
genome is accomplished by copying the viral RNAs into complementary RNA templates 
which in turn are used for production of progeny viral genome. Both cRNA and vRNA 
are encapsidated by the NP. Newly synthesized vRNPs are then transported back to the 
cytoplasm in a process that involves the participation by both M1 and NS2 proteins [67-
9 
69]. (3) Assembly and budding take place at cholesterol-rich lipid raft microdomains in 
the plasma membrane with RNPs and viral structural proteins [70]. Intrinsic interactions 
of the viral glycoproteins (HA and NA) with lipid rafts through their transmembrane 
domains are necessary in preparation for the budding process [71-72]. Outward bending 
of the plasma membrane caused by the clustering of HA and NA in lipid rafts is likely to 
initiate bud formation [73-74]. As a result of specific binding with both HA and NA, viral 
matrix (M1) protein is recruited into the budding assemblage [75], and M1 protein 
polymerization at the budding site has been postulated to drive the elongation of the 
emerging bud [76]. Additionally, M1 binding to viral RNPs is believed to direct 
incorporation of the viral genome into the forming virion [40]. Once formed, the budded 
virion is released by M2-mediated membrane scission at the boundary between the bud 
neck and cellular plasma membrane [77]. NA subsequently cleaves the HA-sialic acid 
bonds on the host cell, which allows for the final release of newly formed virions into the 
external environment [78].   
 
Section III: The Pathogenesis of Influenza A Virus 
 
1. Birds 
The natural reservoirs for all influenza A viruses are wild aquatic birds, in which 
influenza A viruses have reached an optimal evolutionary equilibrium. Viruses replicate 
in the gastrointestinal tracts of the hosts, leading to the excretion of large amounts of 
viruses in their feces usually in the absence of clinical signs [79]. In domestic birds, 
including chicken and turkeys, most strains cause an asymptomatic or mild infection, 
with presentation of mild respiratory disease, nasal discharge, fever, lethargy and 
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declined egg laying. Virus replication is restricted to the respiratory and intestinal tracts. 
The mortality is generally low and these strains are classified as low pathogenic avian 
viruses [80]. In contrast, some strains, known as highly pathogenic viruses, cause rapid, 
fatal disease with extremely high mortality in domestic poultry. To date, outbreaks of 
highly pathogenic avian influenza viruses are restricted to H5 and H7 subtypes. These 
viruses spread systemically, including to the brain. Typical clinical symptoms consist of 
severe depression, cessation of egg production, high fever, respiratory signs, diarrhea, 
edema of the head and neck, and subcutaneous hemorrhage. These highly pathogenic 
avian influenza viruses are restricted to the H5N1 and H7N7 subtypes [81]. 
2. Pigs 
Influenza in pigs was first recognized in 1918, at the same time as the devastating 
human influenza pandemic [82]. Three subtypes H1N1, H3N2 and reassortant H1N2 
circulate in swine population [83]. The virus attacks epithelial cells of the respiratory 
tract and the infection is usually restricted to the respiratory system. Virus isolation from 
extra-respiratory organs is very rare [84]. Most commonly, swine influenza is an acute 
respiratory disease characterized by fever, anorexia, lethargy, sneezing, coughing and 
nasal discharge. The infected pigs usually recover within 7-10 days. Morbidity is very 
high, but mortality is usually low. Pigs can suffer considerable weight loss during the 
outbreak, which causes economic impact for the producers. In addition to clinical 
outbreaks, subclinical infections are also very common [85].  
3. Horses  
Equine influenza is an acute respiratory disease. Typical clinical presentations by 
both H7N7 and H3N8 viruses in natural outbreaks include a sudden onset of fever, 
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anorexia, depression, nasal discharge and coughing, although limited data collected from 
natural outbreaks show that the H3N8 subtype virus seems to cause more severe clinical 
symptoms than the H7N7 subtype [13]. Mortality is usually low, though in some cases 
relatively high mortality can be the result of secondary bacterial infections. Damage to 
the respiratory epithelial cells by virus replication facilitates bacterial invasion. Equine 
influenza is usually a self-limiting disease. Uncomplicated recovery happens within 1 to 
2 weeks after infection. Nevertheless, the disease has a significant impact on the horse 
industry because of both performance failure and economic loss associated with the 
outbreak [12, 86].  
4. Humans  
The disease severity of human influenza can range from asymptomatic infections 
to serious illness with fatal outcome. Most commonly, seasonal outbreaks or epidemics 
are mild. Typical clinical symptoms are fever, headache, sore throat, malaise, anorexia 
and cough. The virus replicates in the epithelium of both the upper and lower respiratory 
tracts [2]. People of all ages can be infected; and the severity of illness is greatest in 
infants, the aged, and those with underlying medical conditions, who are at high risk of 
developing severe complications, such as viral or secondary bacterial pneumonia [87].  
Since 1997, direct natural infections of humans with avian influenza viruses of the 
H5N1, H7N7 and H9N2 subtypes have been documented. Outbreaks of avian H7N7 and 
H9N2 influenza viruses in humans were not severe. The predominant clinical 
manifestation associated with those outbreaks was conjunctivitis. The flu-like symptoms 
were observed in several patients. Among them, only one person died from pneumonia 
[88-89]. In contrast, human avian H5N1 influenza virus infection is highly pathogenic, 
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resulting in high mortality. People of all ages are susceptible to avian H5N1 virus 
infection. Primary clinical signs include high fever and lower respiratory tract symptoms 
such as cough and dyspnea. Viral pneumonia is present in most cases. Chest X-ray 
showed features consistent with pneumonia. Conjunctivitis or upper respiratory 
symptoms are not common. Gastrointestinal symptoms including diarrhea, vomiting and 
abdominal pain occurred more frequently. Central nervous system manifestations have 
been reported in only one patient, and therefore are considered to be rare. Ultimately, 
patients died from acute respiratory disease syndrome or multi-organ failure. The 
mortality rate of avian influenza H5N1 infections in human was 60% [90-93]. Avian 
H5N1 influenza virus replicates in the respiratory system, and no report so far has 
revealed that virus replication occurs in extra-pulmonary organs [94]. Fatal cases were 
characterized by highest viral loads, indicating a positive correlation between virus 
burden and disease severity [95]. High viral loads were suggested to induce 
hypercytokinemia and hyperchemokinemia. Higher serum levels of proinflammatory 
cytokines and chemokines have been detected in many patients [95-97]. Pathological 
findings in the lungs, such as hemophagocytic syndrome, were consistent with an 
overwhelming inflammatory response [96-98]. In severe cases, lymphopenia and 
thrombocytopenia were also observed [90-91].  
5. Mice 
Mice are not a natural host for influenza virus, but can be infected experimentally. 
The advantages of the mouse model for influenza include the availability of various 
reagents, defined genetic background, easy handling and sufficient number for statistical 
power. Intranasal infection of mice with most virus strains, including human influenza 
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viruses, results in a largely asymptomatic infection, though virus can be isolated from the 
respiratory tract at a relatively high titer. Viral spread to extrapulmonary organs is 
extremely rare and clearance of virus in the lung can be completed within 7 days after 
infection [99-100].  
To study influenza pathogenesis and immunity in a mouse model, viruses have to 
be adapted by a number of serial passages in the lungs of mice with an aim to increase 
virulence and pathogenicity. Mouse-adapted human influenza A/PR/8/34 (H1N1) virus is 
one example of such adaptation whereby this adapted virus attacks the respiratory system 
causing severe viral pneumonia after intranasal inoculation [101]. Another human 
influenza H1N1 virus, A/WSN/34 strain, which was derived by serial intracerebral 
passages in mice [102], has been extensively used to study neuropathogenesis of human 
influenza virus infection in mice [103]. This mouse-adapted neurovirulent strain causes 
fatal encephalomyelitis when inoculated intracerebrally into adult mice, or in neonates 
after intranasal inoculation [104], but fails to invade the brain of immunocompetent mice 
following intranasal infection [105]. In contrast, highly pathogenic avian influenza H5N1 
and H7N7 viruses are pathogenic in mice without prior adaptation. Intranasal infection of 
BALB/c mice with highly pathogenic avian influenza H7N7 viruses leads to viral spread 
to extrapulmonary organs such as spleen and brain [106]. Highly pathogenic avian 
influenza H5N1 viruses can display either high or low pathogenicity in mice. Replication 
of low pathogenic avian viruses was restricted to the respiratory tract and infection was 
generally nonlethal with virus clearance completed around 7 days. In contrast, lethal 
strains replicated in multiple organs, including brain, spleen, heart and kidney, in addition 
to the respiratory system. Most deaths occurred within 9 days. Obvious clinical signs of 
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infection characterized by ruffled fur, hunched posture, inappetance and labored 
breathing were usually noticed within 4 days of infection.  [107-109]. Unlike influenza in 
natural hosts, mice infected experimentally with influenza virus fail to display fever 
during the course of infection [108]. Fatally infected mice had a severe interstitial 
pneumonia with apparent accompanying infiltration of immune cells and erythrocytes 
[108]. Neuropathological signs were characterized by neuronal degeneration and 
inflammatory infiltrates of granulocytes and mononuclear cells in the brain stem and 
spinal cord [110]. Several studies reported that lethal H5N1 infection also caused 
depletion of leukocytes and lymphocytes in peripheral blood and lymphoid organs [111-
112]. Exaggerated expression of proinflammatory cytokines and chemokines in the lungs, 
including IL-1β, IL-6, TNF-α and MIP-1α, was another finding in H5N1 virus lethal 
infection [106-107, 113]. In summary, systemic spread of virus, severe viral pneumonia, 
aberrant cytokine expression and lymphopenia were associated with the fatal outcome of 
H5N1 infection in mice. 
 
Section IV: The Immune Responses to Influenza A Virus Infection 
 
The immune responses to the influenza A virus infection have been well studied 
in humans and in mouse models. The initial infection occurs in the epithelia of the upper 
respiratory tract, and later, the infection spreads to the lower respiratory tract and 
leukocytes. In response to infection, infected cells produce interferons, chemokines and 
many other cytokines [114-117]. IFN-α/β bind to their specific receptors on neighboring 
cells and subsequently induce the expression of down-stream “antiviral proteins” such as 
the Mx and dsRNA-dependent protein kinase (PKR) through the JAK-STAT signaling 
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pathway [118]. Release of proinflammatory cytokines and chemokines mainly by 
resident alveolar monocytes/macrophages, notably IL-8, MCP-1, MIP-1, IL-1β, IL-6 and 
TNF-α, leads to recruitment of circulating leukocytes and lymphocytes to the site of 
infection [119]. Some of these early cytokines activate natural killer cells, which are 
known to be key players in the early defense against virus infection by lysing virus-
infected cells and secreting a variety of cytokines, which in turn regulate adaptive 
immune response [120-121] . Another important player in the innate immune response is 
the complement system. Once activated during virus infection, complement components 
bind to the virus, enabling phagocytes to destroy the pathogens [122]. All of these 
mechanisms are involved in the antigen non-specific innate immune response, whose task 
is to limit viral spread until the antigen specific adaptive immune response can be 
activated for the resolution of infection, which usually takes about 7 days [119]. The 
adaptive immune response consists of humoral and cellular-mediated immunity. Cellular 
immune responses are mediated by CD4+ and CD8+ T cells. Activated CD8+ T cells lyse 
infected cells. Besides the cytolytic function, CD4+ T cells can also facilitate both 
humoral and cellular immune responses [123]. Antibodies specific for the HA and NA 
surface proteins of the virus are important for recovery from primary influenza virus 
infection and in protection from re-infection [124]. In the following review sections, the 
focus will be on the IFN-induced Mx protein and inflammatory response. 
1. Interferons 
IFNs belong to a large family of cytokines and can be divided into two major 
types: type I and type II. Type I IFNs consist primarily of IFN-α and IFN-β, which are 
synthesized by most cell types including epithelium and monocyte/macrophage in 
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response to virus infection. These cytokines have essential roles in the innate immune 
response against viruses [125-126]. The type II IFN consists of a single member, IFN-γ, 
which is predominantly produced by natural killer cells and T lymphocytes. IFN-γ is an 
important regulator of cellular immune responses [127].  
Once synthesized, IFN-α/β binds to its receptor on the cell surface. This event 
leads to the activation of tyrosine kinase Jak1 and Tyk2, which then phosphorylate and 
activate STAT1 and STAT2. Phosphorylated STAT1 and STAT2 form a heterodimer and 
translocate to the nucleus, where they form the transcription factor complex called the 
IFN-stimulated gene factor-3 (ISGF-3) with IRF-9. The transcription of interferon-
stimulated genes will be initiated when the ISGF-3 complex binds to the promoter region 
of these genes [128]. Type I IFN is known to induce the synthesis of several hundred 
cellular proteins [129]. The functions of most IFN-induced proteins remain elusive. A 
few of them such as Mx, PKR and 2’-5’ oligoadenylate synthetase have been studied in 
some detail. The IFN-induced antiviral Mx protein is discussed further below.  
2. Mx 
The Mx proteins were discovered as IFN-induced proteins in an inbred mouse 
strain (A2G) that showed antiviral activity against influenza A viruses [130-131]. The 
mouse Mx1 protein is localized in the nucleus [132], while the Mx2 protein, which is 
functional only in feral strains, is localized in the cytoplasm [133]. Rats produce three Mx 
proteins, one is a nuclear protein while the other two are cytoplasmic proteins [134]. Of 
note, most strains of inbred mice (e.g. BALB/c) carry defective Mx genes and as a result 
they are susceptible to influenza A virus infection [135]. In humans, two Mx proteins 
have been found (MxA and MxB) and both are localized in the cytoplasm [136]. 
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However, human MxB has no antiviral activity [137]. The Mx proteins were also 
identified in horses and reported to reside in the cytoplasm [138-139], but their functions 
remain unknown.  
Mx proteins are GTPases that belong to the dynamin superfamily of large 
GTPases [140]. The mouse Mx1 protein inhibits the replication of Orthomyoviruses, such 
as influenza A viruses and Thogotoviruses, in the nucleus by blocking the virus 
transcription [132, 141-142]. The murine Mx2 protein confers resistance to Vesicular 
Stomatitis Virus and Bunyaviruses, which replicate in the cytoplasm [133-134, 143-144]. 
Irrespective of the virus replication site in host cell, the human MxA protein displays 
antiviral activity against a wide range of RNA viruses including Orthomyxoviruses, 
Bunyaviruses, Paramyxoviruses, Rhabdoviruses, Togaviruses, Picornaviruses, and even a 
DNA virus (Hepatitis B virus) [145-148].  
3. Inflammatory responses 
Influenza A virus can replicate in airway epithelial cells and lung macrophages 
and dendritic cells [149-151]. Virus-infected epithelial cells release limited amounts of 
cytokines and chemokines, such as MIP-1, RANTES, IL-8 and IFN-α/β [114-115, 125]. 
In contrast, pulmonary monocytes/macrophages produce a broader spectrum of 
inflammatory mediators in response to virus infection, including MIP-1, MCP-1, MCP-3, 
IP-10, IL-1, IL-6, IL-18, TNF-α, IFN-γ and IFN-α/β [116-117, 152-154]. Dendritic cells, 
as important mediators of innate and adaptive immune responses to influenza virus 
infection, have been reported to produce multiple chemokines and cytokines, such as 
IFN-α/β, IL-6, IL-8, IL-12 and TNF-α [155-157]. It is believed that pulmonary 
macrophages and DCs are the major contributors of inflammatory cytokine production.  
18 
Chemokines are a subfamily of cytokines that function as chemoattractants for 
leukocytes. They are approximately 70 to 100 amino acids in length and exhibit from 20-
90% amino acid homology to each other [158]. The hallmark of pulmonary inflammation 
following influenza virus infection is the trafficking of effector leukocytes from the 
peripheral blood flow into inflamed tissue. This process is mainly directed by 
chemokines [159]. The neutrophils, which are primarily activated by IL-8, dominate the 
early influx of leukocytes. Activated neutrophils phagocytose virus-infected cells and 
therefore are recognized to be the first line of defense [160]. Other chemokines such as 
MCP-1, MIP-1 and RANTES appear to act on other leukocytes and lymphocytes [159]. 
Large numbers of chemokines and cytokines produced by macrophages and DCs, 
including the most important cytokines IL-1, IL-6, TNF-α and IFN-γ, will further 
elaborate the inflammatory response. These cytokines were shown to induce systemic 
symptoms such as fever, headache and appetite loss by acting on the central nervous 
system [161-164]. In addition, IL-1, IL-6 and TNF-α are involved in the activation and 
recruitment of natural killer cells and lymphocytes into the infected lungs [165-166]. 
Overall, cytokines play a pivotal role in the regulation of inflammatory and immune 
responses.  
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Research Objectives 
 
Equine H7N7 influenza viruses share many remarkable pathogenic properties 
with the highly pathogenic avian influenza viruses, i.e. lethal infection in BALB/c mice 
[167], the HA gene from an equine H7N7 influenza virus bestows a less pathogenic avian 
influenza virus with the lethal phenotype for chickens [168] and the equine H7N7 
influenza virus HA gene contains multibasic amino acids at the cleavage site, which is 
therefore theoretically susceptible to cleavage by ubiquitous host proteases [169]. 
However, the infection by the equine H7N7 influenza virus in its natural host is strikingly 
different, causing only mild, self-limiting upper respiratory disease [12-13]. Why the 
equine H7N7 influenza virus displays the differential pathogenicity in BALB/c mice and 
horses still remains an open question. Thus, the overall objective of this research work 
was to investigate the mechanism(s) underlying the observed pathogenicity difference of 
the equine H7N7 influenza viruses in these two animal species.  
As the first line of inducible defense against invading pathogens, the host innate 
immune response is immediately mounted upon influenza A virus infection to impede 
viral spread and to activate the subsequent adaptive immune response, which demands a 
few days to consolidate and is pivotal for virus elimination and the ultimate recovery 
from the disease [119]. Therefore, the quality of the innate immune defense against the 
viral infection is a critical determinant of the magnitude and quality of the following 
adaptive immune response. During natural and experimental influenza virus infection, it 
usually takes 5-7 days for the adaptive immunity to be effective for viral clearance and 1-
2 weeks for clinical recovery in immunocompetent subjects without complicated 
infection [2, 12, 170]. In stark contrast, deaths occur as early as day 4 after infection with 
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equine H7N7 or the highly pathogenic avian H5N1 influenza virus in BALB/c mice [109-
111, 167], which indicates the failure of the innate immune response as the only defense 
weapon for the disease within the early time window. Evidence accumulating from 
studies in BALB/c mice with the highly pathogenic avian H5N1 influenza virus reveals 
that sustained high viral load in the lungs early on and an exacerbation of 
proinflammatory response are central to the unusual pathogenesis of this virus in the 
mouse model [95, 106, 113, 171]. It was therefore hypothesized that the pro-
inflammatory responses of horses and BALB/c mice during the equine H7N7 influenza 
virus experimental infection are different.  
To test the experimental hypothesis, the first specific aim was to compare the 
innate immune responses in terms of the intensity of pro-inflammatory cytokine response 
in BALB/c mice after experimental infection with a representative strain of either equine 
H7N7 or H3N8 influenza virus, respectively. The second specific aim was to determine 
whether the developmental state of the innate immune system affects the comparative 
pathogenesis of equine H7N7 and H3N8 viruses in a chicken embryo model. Different-
aged chicken embryos, which differ in developmental stages of the interferon system, 
were inoculated with three different doses of either virus, and cumulative mortality rates 
following inoculation were recordered to determine and compare the virulence of these 
two viruses for chicken embryos. 
Although limited field observations indicate that equine H7N7 viruses are less 
pathogenic than H3N8 viruses in the horse [172-173], no studies so far have been 
reported to investigate the comparative pathogenicity of these two subtypes in horses by 
use of experimental infections. Moreover, knowledge about equine cytokine responses to 
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the equine H7N7 virus infection is completely absent. To this end, the third specific aim 
was to compare pathogenesis and inflammatory cytokine responses in horses following 
exposure to either virus. The result of this experiment will then be used to compare to 
that of the BALB/c mouse study to test the hypothesis proposed above.  
It has been demonstrated that influenza virus can infect alveolar macrophages in 
vivo after intranasal challenge of ponies [174]. However, to date there are no published 
reports addressing whether ex vivo-cultured equine peripheral blood mononuclear cells 
(PBMCs) or monocyte-derived macrophages support the growth of influenza virus. If the 
highly permissive equine immune cell culture can be established, this in vitro research 
model could be exploited to investigate the equine cytokine response following influenza 
virus infection and to extend the current in vivo study in the future. The fourth specific 
aim of this dissertation was to determine whether equine PBMCs or blood-derived 
macrophages support the prolific replication of equine influenza virus.  
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CHAPTER TWO 
Materials and Methods 
Viruses  
Influenza A/equine/New York/49/73 (H7N7) and influenza 
A/equine/Kentucky/5/2002 (H3N8) were used throughout all experiments in this 
dissertation. Both virus strains were grown and propagated in 10-day-old chicken 
embryonated eggs. To avoid generation of von Magnus-type defective interfering (DI) 
particles [175] during virus preparation, which are non-infectious due to internal deletion 
of genomic RNA segments [176], seed virus was 10-fold serially diluted in phosphate 
buffered saline (PBS) supplemented with 1% PSA antibiotics (100 U/ml penicillin, 100 
µg/streptomycin, 0.25 µg/ml fungizone; BioWhittaker), and 100 µl from each dilution 
was inoculated into the allantoic cavity of each egg. All eggs were incubated for 48 hours 
at 37°C in an incubator with humidity. After incubation eggs were removed to 4°C for 24 
hours. Allantoic fluids were then harvested, following by clarification by centrifugation 
at 1000 ×g for 10 minutes. Virus titers were determined by hemagglutination (HA) and 
EID50 assays (to be described below). Allantoic fluids of the eggs with the largest 
dilution number combined with the highest HA titer were collected and pooled to make 
stock virus. The ratios of EID50 titer/HA titer for the H7N7 and H3N8 virus stocks were 
1.06 × 106 and 3.4 × 105, respectively, which is indicative of a highly replication-
competent virus preparation and a very low incidence of DI particles. The virus-
containing egg fluids were then aliquoted and stored at -70°C for later use. 
Preparation of 0.5% chicken red blood cells 
Chicken red blood cells used for the HA assay were collected weekly from 
healthy male non-vaccinated leghorn chickens. Approximately 5ml of chicken blood was 
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collected from the wing vein into a vacutainer blood collection tube supplemented with 
sodium heparin (BD, Franklin Lakes, NJ). Blood was washed with physiological saline 
solution two times and centrifuged at 500 × g for 5 minutes at 4 °C. After the supernatant 
was removed, the cell pellet was washed again with PBS and centrifugated at 500 × g for 
20 minutes at 4 °C to pack the cell pellet, from which 0.25 ml was pipetted and mixed 
with 50 ml cold PBS to make 0.5% chicken red blood cells. 
Hemagglutination Assay (HA) 
The HA test was used to determine the titer of influenza virus based on the fact 
that influenza virus can agglutinate erythrocytes through the interaction between the 
hemagglutinin protein and sialic acid residues on the cell surface. Briefly, samples (50 µl) 
were serially diluted 2-fold in PBS in a u-bottom microtiter plate. A negative control 
using PBS was included in the test. Each well was mixed with equal volume of 0.5% 
chicken red blood cells and incubated at room temperature for 30 minutes. Negative was 
indicated by the presence of a red button in the well. The HA titer was expressed as the 
reciprocal of the highest virus dilution exhibiting complete hemagglutination. 
EID50 Assay 
The 50% egg infectious dose (EID50) titers for the H7N7 and H3N8 viruses were 
calculated by the method of Reed and Muench (1938). To perform an EID50 assay a 
series of 10-fold dilutions of each virus was made in PBS with 1% PSA antibiotics. 0.1 
ml of each dilution was injected with syringe and needle into the allantoic cavity of 10-
day-old chicken egg (4 eggs/dilution). The eggs were sealed with melted paraffin and 
incubated at 37°C in a humidified incubator. At 72 hours post injection the eggs were 
transferred to 4°C for 24 hours. Allantoic fluids were harvested and then clarified to 
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remove any egg debris by centrifugation. HA assay was employed as described above to 
identify the eggs in which virus grew. The virus titer was determined by the Reed and 
Muench method, and expressed as EID50/ml. 
Horses and experimental challenge 
6 seronegative mares, aged at least 19 months (Table 2.1), were placed within a 
closed tent where they were challenged with 1 × 107 EID50 units of Influenza 
A/equine/New York/73 (H7N7) virus/m3 of tent (21.5 m3) for 45 minutes using a 
nebulizer. Another group of 4 seronegative horses of mixed sex, aged 11-12 months 
(Table 2.1), were infected experimentally with 1 × 107 EID50 units of Influenza 
A/equine/Kentucky/5/2002 (H3N8) virus/m3 of tent (33 m3) in nebulized aerosols for 45 
minutes. The challenge fluids consisted of virus-containing allantoic fluids and PBS. The 
care, maintenance and use of all horses followed the Guidelines for the Care and Use of 
Agricultural Animals in Agricultural Research, U.S. Department of Agriculture. 
Virus isolation from the horses 
Nasal swabs were collected daily up to day 8 post challenge. From selected days, 
titers of excreted virus in nasal secretions were quantified by inoculation into 10-day-old 
chicken embroynated eggs. Viral titers were calculated by the EID50 method.  
Clinical examinations of the horses 
Rectal temperatures were monitored daily during the study, and subjects with 
rectal temperature more than 38.9°C were defined as pyrexic. Each horse was examined 
daily with the assistance of licensed veterinarian for clinical signs associated with equine 
influenza, including coughing, nasal discharge, depression and anorexia. Clinical signs of 
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horse depression may include loss of appetite, lack of motivation and head drooping. A 
system which was adapted from [177] (Table 2.2 ) was used to score clinical signs.  
Equine peripheral cytokine mRNA response 
Peripheral blood was collected using PAXgene collection tubes (Qiagen, Hilden, 
Germany). The tubes were centrifuged for 10 minutes at 3000 × g, and then the 
supernatant was decanted. The lysed cell pellet was resuspended in 5 ml of RNase-free 
water. The tubes were re-centrifuged and the supernatant was removed. The resultant cell 
pellet was resuspended in 350 μl PAXgene Buffer BR1, 300 μl Buffer BR2 and 40 μl 
Proteinase K, and then was incubated for 10 minutes at 55 °C. After centrifugation, the 
supernatant was removed and the lysed cell pellet was mixed with 350 μl of 100% 
ethanol and then applied to the PAXgene spin column and centrifuged for 1 minute at 
10,000 × g. The centrifugation was repeated again with the Buffer 3, 4, and 5, 
respectively. The isolated RNA was denatured by incubation at 65°C for 5 minutes 
before cDNA synthesis.     
The cDNA was synthesized from DNase-treated total RNA using an oligo(dT) 
primer and the stratascript® first-strand synthesis system (Stratagene, La Jolla, CA). 
Primer/probe sets specific for detection of equine β-Gus, IFN-γ, IL-1β, IL-6, IL-8, IL-10, 
IL-18, TNF-α and Mx (Table 2.3) were designed to cross the exon-exon junction for 
discrimination between genomic DNA and cDNA derived from mRNA (Assays-by-
Design, Applied Biosytems). mRNA expression was quantified by Applied Biosystems 
7500 fast real-time PCR system (Applied Biosystems, Foster City, CA). PCR cycling 
conditions comprised an initial enzyme activation step at 95°C for 20s, and 40 cycles of 
95°C for 3s (denaturation) and 60°C for 30s (annealing/extension). Duplicate wells were 
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run for each 10µl PCR reaction containing 1 µl 10× primer/probe set for the gene tested, 
4 µl cDNA template and 5 µl 2 × Taqman® fast universal PCR master mix (No 
AmpErase® UNG).  
The RT-PCR raw data were exported to the LinReg PCR software [178] to 
calculate the amplification efficiency of each primer pair. Primer efficiency calculations 
were based on the slope of a linear regression line containing 4–6 data points, and only 
values with an R2 (squared correlation coefficient) greater than 0.97 and an efficiency 
ranging between 1.7 and 2.2 for each amplicon were considered. The value of each PCR 
cycle threshold (CT), which is defined as the cycle number at which the fluorescent signal 
passes the threshold, was then corrected by the corresponding PCR efficiency for 
individual primer set. The relative quantification of each target mRNA was calculated by 
the method 2-ΔΔCT [179] , where ∆∆CT = ∆CT samples for target gene at a certain time 
point − ∆CT the calibrator (averaged ∆CT of all horses within the same group for each 
individual gene at day 0) for the target gene, and ∆CT = CT target gene − CT endogenous 
control gene. The β-glucuronidase (β-GUS) was used as an internal endogenous control 
gene [180]. Results were expressed as the mean fold change in individual mRNA 
expression by the H7N7 or H3N8 groups.  
Inoculation of mice 
Female, 7-week-old BALB/c mice (Harlan Sprague-Dawley, Indianapolis, IN) 
were inoculated intranasally with 40 µl of saline containing 106 EID50 units of either the 
H7N7 or H3N8 virus. The viruses were purified by the method of sucrose density 
gradient centrifugation. Briefly, a 15 ml of continuous sucrose density gradients ranging 
from 25% to 70% (w/v) sucrose was added into Beckman ultracentrifuge tubes and then 
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overlayed with virus-containing allantoic fluid without disturbing the interfaces. All tubes 
were carefully balanced before ultracentrifugation at 26,000 rpm (in a Beckman SW-28 
rotor) for 90 minutes at 4 °C. The visible virus-containing band was collected through 
puncture at the very bottom of the tube using a needle and subsequently mixed with cold 
PBS for a second centrifugation. The resultant pelleted virus was resuspended and 
aliquoted in PBS for storage at -70°C. A group of 6 mice for each virus were monitored 
daily for morbidity and mortality, and also measured for body weight up to day 8 post 
inoculation. Other groups of 5 mice per virus per day were euthanized daily until day 7 
post inoculation. Brain, spleen, heart, liver, kidney and bronchioalveolar Lavage (BAL) 
samples were collected and immediately stored at -70°C for later determination of virus 
replication as described below. Cytokine protein assay was measured from BAL samples 
as described below. All experiments using BALB/c mice were approved by the 
University of Kentucky Institutional Animal Care and Use Committee. 
Virus titration in the mouse tissues  
Tissues of brain, spleen, heart, liver and kidney were homogenized in 1ml of cold 
PBS, and clarified homogenates were titrated in 10-day-old eggs from an initial 1:10 
dilution in PBS. BAL fluids were used for pulmonary virus titration. Virus titers were 
calculated by EID50 using the method of Reed and Muench (1938) and expressed as 
mean ± SD. 
Quantification of cytokines and chemokine in the mouse lungs 
BAL fluids from day 2 to day 7 p.i. were assayed for protein levels of IL-6, IFN-
γ, TNF-α, IL-10, MCP-1 and IL-12 by use of a Cytometric Bead Array kit (BD, Franklin 
Lakes, NJ) according to the manufacturer’s manual. Briefly, the capture antibody-coated 
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beads, PE-conjugated detection antibodies, and antigen standards or test samples were 
incubated together for two hours to form sandwich complexes. Flow cytometry data 
acquisition was performed on a BD FACSCalibur flow cytometer (Becton Dickinson, 
San Jose, CA). CellQuest software was used for data analysis (BD Biosciences). The 
detection limit of the assay is 5 pg/ml (IL-6), 17.5 pg/ml (IL-10), 52.7 pg/ml (MCP-1), 
2.5 pg/ml (IFN-γ), 7.3 pg/ml (TNF), and 10.7 pg/ml (IL-12p70). 
Inoculation of chicken embryos 
7, 9 and 11-day-old white leghorn chicken embryonated eggs from the same flock 
were used. A candling light was used to determine the position of the embryo eyes, which 
was then marked on the shell with a pencil. The shell was disinfected with 75% alcohol 
and a hole was drilled above the pencil mark along the line of air sac. A 25-gauge needle 
was inserted vertically into the hole and 0.1ml inoculum (virus-containing allantoic fluid), 
which was diluted in PBS supplied with 1% PSA antibiotics, was injected into the 
chorioallantoic sac of the embryo using a tuberculin syringe. The opening was sealed 
with melted paraffin, and the eggs with blunt end up were returned to a 37°C humid 
incubator. Eight eggs in each age group were inoculated with 3 different doses (102, 104 
and 106 EID50 units/egg) of the H7N7 or H3N8 virus. A group of 8 eggs was inoculated 
with each dose. Inoculated eggs were candled daily to determine death for the calculation 
of cumulative mortality. Death was ascertained by absence of embryonic movement.  
Gene sequencing of the H7N7 virus HA cleavage site 
Viral RNA isolation was carried out by QIAamp® viral RNA mini kit (Qiagen, 
52904) according to the manufacturer’s manual. cDNA was synthesized with a 12-base 
oligonucleotide primer (5’ AGCAAAGCAGG), which can form base pairs with the 
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widely conserved nucleotide sequences at the 3’ termini of influenza A virus RNAs, by 
using superscript™ first-strand synthesis system (Invitrogen, 11904-018). The 
sequencing reactions for the H7N7 HA gene were performed with the primers listed 
below (Table 2.4) using the Bigdye Terminator V1.1 cycle sequencing kit (Applied 
Biosystems, Foster City, CA). The HA cleavage site sequence of the H3N8 virus was 
derived from GeneBank (Accession ID, AY855341). 3M sodium acetate and 100% 
ethanol were used to precipitate and purify the sequencing products. After washing twice 
with 75% ethanol, the pellet was dried under a vacuum and resuspended in 20 µl of Hi-
Di™ Formamide for loading on an ABI 310 genetic analyzer (Applied Biosystems) 
according to the manufacturer’s instructions. The data were analyzed with the Vector 
NTI suite 9 software package (InforMax Inc, Frederick, MD). 
Isolation, culture and infection of equine peripheral blood mononuclear cells (PBMCs)  
Blood was collected from healthy, adult horses by venipuncture into heparinized 
tubes. Upon returning to the lab, blood was diluted with phosphate buffed saline (PBS) at 
1:1 ratio. 4 ml histopaque®-1077 (Sigma, St. Lous, MO) was added into a 15 ml conical 
centrifuge tube, and prediluted blood was gently layered onto histopaque®-1077. Tubes 
were balanced and centrifuged at 400 x g for 30 minutes at room temperature without 
braking (Beckman GS-6KR Centrifuge; Rotor type GH-3.7). After centrifugation, a 1-ml 
sterile pipette was used to penetrate the top plasma layer and aspirate the white cell ring 
containing mononuclear cells at the interface between plasma and Histopaque. PBMCs 
were transferred into a clean conical centrifuge tube and mixed with 10 ml PBS by gentle 
inversion. Tubes were centrifuged again at 250 x g for 10 minutes at room temperature 
with braking. Supernatant was aspirated, and pellet was resuspended with 10 ml PBS. 
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Centrifugation was repeated at 250 x g for 10 minutes at room temperature with braking. 
After removing the supernatant, the cell pellet was resuspended with complete RPMI-
1640 medium supplied with 10% autologous serum, 100 U/ml Penicilin G, 100 µg/ml 
Streptomycin, and 0.25 µg/ml amphotericin B, and then was plated in a 24-well plate. For 
influenza virus infection, culture medium was replaced with serum-free RPMI-1640 
medium supplied with 1 μg/ml TPCK-treated trypsin, then cells, which were plated in a 
24-well plate (in a volume of 100 µl of media per well), were infected at a multiplicity of 
infection of 5 EID50 units per cell with either of the two viruses in allantoic fluid. After 
absorption of virus for 1h at 37 °C in 5% CO2, cells were washed five times with warm 
PBS then incubated in serum-free RPMI-1640 medium supplied with trypsin. At 0 and 24 
hours post infection, supernatants of infected cell culture were collected for extracellular 
virus titration by EID50 in embryonated chicken eggs, and cells were collected and 
processed for indirect immunofluorescence assay. 
Monocyte-derived macrophage isolation, culture and infection 
Macrophages were derived from blood monocytes, which were isolated from 
PBMCs. The isolation and culture of PBMCs were the same as descried above. To isolate 
monocytes from PBMCs, the cells were allowed to adhere onto 12 or 24-well plates for 
2h at 37 °C in 5% CO2. After monocyte binding, non-adherent cells (most are 
lymphocytes) were removed and adherent cells were then allowed to differentiate for 7 
days with the medium being changed every other day before infection [181]. The purity 
of macrophages was measured by performing cytochemical assay for the non-specific 
esterase activity using the α-naphthyl-acetate esterase kit (Sigma) [182]. To infect 
macrophages with influenza virus, cells were washed twice in warm PBS and then culture 
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medium was replaced with serum-free RPMI-1640 medium supplied with 1 μg/ml 
TPCK-treated trypsin. Macrophages were exposed to infection at a multiplicity of 
infection of 5 EID50 units per cell with either of the two viruses indicated above. After 
virus absorption for 1h at 37 °C in 5% CO2, cells were washed five times with warm 
PBS then incubated in serum-free RPMI-1640 medium supplied with trypsin. 
Supernatants of cell culture were collected for extracellular virus titration by EID50 on 
chicken eggs and for TNF-α protein analysis by using the equine TNF-α screening set 
(Endogen, Rockford, IL). Also, macrophages were collected and processed at designated 
times post infection for indirect immunofluorescence assay. 
Indirect Immunofluorescence Assay 
Cells were rinsed twice with cold PBS, and then fixed with 3% paraformaldehyde 
for 10 min at room temperature. After washing once with cold PBS, cells were 
permeabilized with 0.1% Triton X-100 in PBS for 10 min at room temperature. Non 
specific antibody-binding sites were blocked by incubation of cells for 1h with 10% 
normal horse serum in PBS (Sigma). Monoclonal primary antibody (Fitzgerald, Concord, 
MA) against influenza virus nucleoprotein (NP) was diluted in blocking solution (1:100 
dilution), and then reacted with cells for 1h at room temperature. After washing three 
times, cells were incubated at room temperature for 1h with FITC-conjugated goat 
antimouse IgG antibody (Pierce, Rockford, IL) (1:400 dilution in blocking buffer), which 
was diluted with 0.02% Evans Blue in blocking solution. Cells were mounted with 
coverslips before examination using Axioplan 2 fluorescent microscope (Zeiss) equipped 
with cytovision©/Genus™ Application software version 2.7 (Applied Imaging). 
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Statistical analysis 
A repeated measures, two-way analysis of variance (RM-ANOVA) was used to 
determine differences in clinical scores and daily rectal temperatures between the two 
viruses over time for the horse challenge study. Since data of horse cytokine mRNA 
expressions was not normally distributed, the values of IFN-γ, TNF-α, IL-1β and IL-18 
relative quantifications had to be log10-transformed first before running the two-way RM-
ANOVA to determine differences in each of the cytokines between the two viruses over 
time. The statistical analysis of horse IL-6, IL-8, IL-10 and Mx data was performed using 
Friedman repeated measures ANOVA on Ranks and Mann-Whitney Rank Sum Test. The 
samples that were identified as outliers by the LinReg PCR analysis were treated as 
missing data in the statistical model mentioned above, and were not considered when 
computing the mean of the respective measurement. The analysis of Spearman Rank 
Order Correlation was used to evaluate the correlation among virus shedding, febrile 
response, clinical severity and cytokine expressions. For mouse challenge study, the 
significant differences in viral titers and mouse body weight loss after the virus infections 
between the two viruses over time were determined using a two-way ANOVA and two-
way repeated measures ANOVA, respectively. Non-parametric analysis (ANOVA on 
RANKS and Mann-Whitney Rank Sum Test) were used to evaluate differences in 
cytokine levels within the H7N7 group mice and between the two groups (IL-10 only) in 
the course of viral infections. Any mouse cytokine with undetectable expression level by 
the assay was valued as 0 in the statistical model. The degree of correlation among the 
expression of individual cytokines, and between the levels of virus replication and 
cytokines in the lung within the H7N7 group were assessed using Spearman Rank Order 
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Correlation. Differences in cumulative chicken embryo mortalities induced by the two 
viruses over the period of observation were analyzed by a Student’s t-test, which was also 
used to determine the significant differences of TNF-α protein levels in cell supernatants 
from the H7N7 virus-infected and mock-infected macrophages. P<0.05 was considered to 
be statistically significant for all statistical analyses performed with SigmaPlot (V11.0) 
(Systat Inc., Richmond, CA). 
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                     Table 2.1 Age of each individual horse in the study 
Treatment (Group) Horse ID Age (month) Sex 
H7N7 virus 85 
160 
C011 
D001 
F017 
F019 
 
>35 
>35 
55 
44 
19 
19 
F 
F 
F 
F 
F 
F 
H3N8 virus G001 
G002 
G005 
G009 
12 
12 
12 
11 
M 
F 
F 
M 
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Table 2.2 Scoring system for clinical signs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Clinical Sign Degree Score 
 
Coughing  
 
 
 
No 
Mild=once during 20 minutes 
Moderate=two or more times during 20 minutes 
 
0 
1 
2 
 
Nasal discharge 
 
 
No 
Mild=transient, slight serous 
Moderate=readily observed mucopurulent 
Severe=copious discharge 
 
0 
1 
2 
3 
 
Depression 
 
 
No 
Present=loss of appetite, lethargy, head down 
 
0 
1 
 
Anorexia 
 
 
No 
Present 
 
0 
1 
 
Labored breathing 
 
Normal  
Mild  
Moderate 
 
0 
1 
2 
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Table 2.3 Sequences of primers and probes used in real-time PCR     
 
      Gene                     Primer/Probe Sequence 
 
      IL-1β 
 
 
 
      Il-6 
 
 
 
      IL-8 
 
 
 
      IL-10 
 
 
 
      IL-18 
 
 
 
      IFN-γ 
 
 
 
      TNF-α 
 
 
 
       Mx 
 
 
 
       β-glucuronidase 
 
   Forward 
   Reverse                                                           
   Probe 
 
   Forward                                                                                                 
   Reverse 
   Probe 
 
   Forward      
   Reverse 
   Probe 
 
   Forward      
   Reverse 
   Probe 
 
   Forward      
   Reverse 
   Probe 
 
   Forward 
   Reverse 
   Probe 
 
   Forward 
   Reverse 
   Probe 
 
   Forward 
   Reverse 
   Probe 
 
   Forward 
   Reverse 
   Probe 
5’-CCGACACCAGTGACATGATGA-3’ 
5’-ATCCTCCTCAAAGAACAGGTCATTC-3’ 
5’-ATTGCCGCTGCAGTAAG-3’ 
 
5’- GGATGCTTCCAATCTGGGTTCAAT-3’
5’- TCCGAAAGACCAGTGGTGATTTT-3’ 
5’- ATCAGGCAGGTCTCCTG-3’ 
 
5’- GCCGTCTTCCTGCTTTCTG-3’ 
5’- CCGAAGCTCTGCAGTAATTCTTGAT-3’ 
5’- CAACCGCAGCTTCAC -3’ 
 
5’- AGGACCAGCTGGACAACATG -3’ 
5’-GGTAAAACTGGATCATCTCCGACAA -3’ 
5’-CCAGGTAACCCTTAAAGTC-3’ 
 
5’- CCTGTGTTTGAGGATATGCCTGATT-3’ 
5’- GCTAGACCTCTAGTGAGGCTATCTT-3’ 
5’- ATTGTACAGACAACGCACCC -3’ 
 
5’-AGCAGCACCAGCAAGCT-3’ 
5’-TTTGCGCTGGACCTTCAGA-3’ 
5’-ATTCAGATTCCGGTAAATGA-3’ 
 
5’- TTACCGAATGCCTTCCAGTCAAT-3’ 
5’- GGGCTACAGGCTTGTCACTT-3’ 
5’- CCAGACACTCAGATCAT-3’ 
 
5’- CCGACAGGAGTTCCAGAAATGG-3’ 
5’- CTGCCACGATACTGATTTTCAAATGT-3’ 
5’- CTTCGCCACCTTTTCG-3’ 
 
5’- GCTCATCTGGAACTTTGCTGATTTT-3’ 
5’- CTGACGAGTGAAGATCCCCTTTT-3’ 
5’- CTCTCTGCGGTGACTGG-3’ 
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Table 2.4 Primers used for sequencing of the H7N7 virus HA cleavage site 
 
Primer Sequence 5'-3' 
HA-697 Forward CCTGGACCAAGACCGCAAAT 
HA-1377 Reverse CTCCACTGCTACGAGGAATTCT 
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CHAPTER THREE 
Results 
Characterization of the H7N7 and H3N8 viruses in BALB/c mice 
As addressed above in the section of research objectives, the aim of experimental 
infection of BALB/c mice with the two subtype viruses was to compare their 
pathogenesis in the mouse model. Mice were infected as described in Materials and 
Methods. Mice inoculated with the H7N7 virus began to lose weight at day 3 post 
infection (p<0.001). By day 7 p.i., there was an approximately 25% loss of their initial 
weight at inoculation (p<0.001) (Figure 3.1A). Pronounced clinical signs of disease 
characterized by ruffled fur, lethargy, hunched posture and labored breathing were 
noticed on day 4 and afterward. By day 8 p.i., all the H7N7-infected mice succumbed to 
death (Figure 3.1B). In contrast to the lethal outcome of the H7N7 virus infection, neither 
weight loss nor clinical symptoms were demonstrated in the H3N8-infected mice during 
8 days of observations, and all mice survived the infection. 
Although the disease progression differed strikingly for the two viruses in 
BALB/c mice, both viruses replicated to a similar degree during the first 2 days of 
infection in the lungs without prior mouse adaptation. However, the H3N8 virus had 
significantly lower lung virus titers than the H7N7 virus after day 2 p.i. (p<0.05) and was 
cleared from the mice at day 7 p.i. (Figure 3.2A), indicating that the H3N8 virus exhibits 
normal sensitivity to the innate immune control of BALB/c mice. In contrast, the H7N7 
virus demonstrated the extraordinary ability to escape the innate host defense and 
multiplied uniformly to high titers in the lung until the death of these mice. Furthermore, 
large amounts of erythrocytes in lung lavage fluids were noticed in four mice out of five 
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within the H7N7-infected group on days 6 and 7 only post infection, which implies the 
occurring of pulmonary hemorrhage. Such a phenomenon was not observed in the H3N8 
group of mice. Virus replication in the brain, heart, spleen, kidney and liver were also 
examined in mice infected with either the H7N7 or H3N8 virus over the course of 
infection. The H7N7 virus displayed efficient replication in the brain in which virus titers 
increased gradually from very early infection until these mice died (day 4 vs day 1, 
p<0.05; day 7 vs day 1, p<0.001) (Figure 3.2B). No virus was isolated from any other 
organs tested. The H3N8 virus failed to spread to organs outside of the respiratory 
system, except for days 2 and 5 on which virus was recovered from the brain of one 
mouse in these groups.  
Cytokine and chemokine protein levels in the lungs of infected mice 
Since the two viruses exhibited a clear disparity of pathogenicity in BALB/c 
mice, the extent of protein expression of inflammatory cytokines induced by each virus 
was examined in the lungs over time (Figure 3.3). In the H3N8 virus-infected mice, the 
presence of IL-6, IFN-gamma, MCP-1 and TNF-α was undetectable by the assay at the 
times of observation except for TNF-α, which was detected at a low level in three mice 
on day 3 (14, 17 and 43 pg/ml, respectively) and one mouse (25 pg/ml) on day 2 p.i., 
respectively. In contrast, the H7N7 virus infection elicited expression of IL-6 in most or 
all mice at each time point examined except on days 2, 3 and 7 p.i. when only a small 
number of animals exhibited the presence of it in the lungs. The expression of IFN-γ in 
mice infected with the H7N7 virus followed a similar pattern as IL-6, but on day 7 p.i., 
IFN-γ was detected in 3 mice. Following exposure to the H7N7 virus, the majority of 
mice showed detectable presence of TNF-α in the lung during the examination period 
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except for days 2 and 7 p.i., on which the assay failed to detect the cytokine in 4 and 3 
animals, respectively. The production of MCP-1 in the H7N7 group was detected in only 
two mice between days 2 and 5 p.i. In contrast, the number of mice with detectable 
expression of MCP-1 increased to five on both days 6 and 7 p.i. The expression of anti-
inflammatory cytokine IL-10 was detected in the lungs of most mice infected with either 
of the two viruses. As for statistical analysis, any samples with undetectable levels of the 
respective cytokines were treated as zero. One-Way ANOVA on Ranks analysis showed 
that neither the H7N7 nor H3N8 virus infection was able to induce significant increases 
in the expression of all cytokines studied here in the lungs of mice during the 
examination period. However, the H7N7 virus induced greater levels of IL-10 expression 
than the H3N8 virus with significant differences on days 2, 6 and 7 p.i. (p<0.05, Mann-
Whitney Rank Sum Test). Neither the H7N7 nor H3N8 virus infection triggered 
detectable IL-12 expression since the assay applied in the present study failed to reveal 
the presence of IL-12 in the lungs. Following the H7N7 virus infection in mice the 
pulmonary expression of TNF-α correlated with that of IFN-γ (correlation 
coefficient=0.56, p<0.05) and IL-6 (correlation coefficient=0.64, p<0.05). However, such 
a relationship between IFN-γ and IL-6 could not be established. Furthermore, the 
expression of IFN-γ also correlated relatively weakly with that of IL-10 (correlation 
coefficient=0.47, p<0.05). The relationship between the virus replication and cytokine 
expression in the mouse lung was also evaluated by Spearman Rank Order Correlation 
analysis. This analysis revealed that the viral replication correlated with the expression of 
TNF-α (correlation coefficient=0.49, p<0.05) and anti-inflammatory cytokine IL-10 as 
well, but in an inverse pattern (correlation coefficient=0.5, p<0.05) (Figure 3.4). In other 
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words, the H7N7 virus replication had a negative correlation with the expression of 
pulmonary IL-10 in BALB/c mice. Near the end of this dissertation, a dot plot graph of 
the expression levels of different pulmonary cytokines in individual mice from the H7N7 
group is also attached (Appendix B).  
The cDNA-derived amino acid sequences of the HA cleavage site of both viruses 
To examnine the composition of amino acids at the HA cleavage site of the two 
viruses, genetic sequences of the two HA genes were obtained and used to deduce the 
corresponding amino acid sequences. This analysis showed that the H7N7 virus used in 
this study contains a series of basic amino acid residues at the HA cleavage site, whereas 
the HA of H3N8 virus has a single basic amino acid residue at the cleavage site (Table 
3.1). Therefore, the HA of H7N7 virus can be cleaved by ubiquitous host proteases 
whereas the H3N8 virus HA can only be activated by trypsin-like proteases distributed 
specifically in the intestinal and respiratory organs.   
Differential cumulative mortality produced by the H7N7 and H3N8 viruses 
The innate immune system develops functionally as the chicken embryo grows 
up. To compare the abilities of both viruses to evade the innate immune control of the 
developing chicken embryo, embryos of different ages were used for virus inoculation in 
this study. As seen in Figure 3.5A, when inoculated into 7-day-old eggs, the H7N7 virus 
at higher doses (104 and 106 EID50 units per egg) induced 100% cumulative mortality by 
day 3 p.i., and more than 80% for the low dose of 102. Similarly, more than 80% 
mortality was produced by the H3N8 virus infection with all 3 different doses. In 9-day-
old eggs (Figure 3.5B), at each of the three doses used, the H7N7 virus infection resulted 
in significantly higher cumulative mortality than that by the H3N8 virus by day 4 p.i. 
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Strikingly, in 11-day-old eggs (Figure 3.5C), the H3N8 infection at all doses tested 
caused less than 13% mortality by day 5 p.i., which was significantly lower than that of 
the H7N7 virus. In conclusion, the present study demonstrates that the H7N7 virus is 
significantly more resistant to the action of the developing innate immune system than 
the H3N8 virus in chicken embryos aged 9 days and older. 
Viral shedding in the horse challenge study 
The results of the comparative study on the pathogenesis of the two viruses in the 
BALB/c mouse model presented above demonstrated that the H7N7 virus was more 
pathogenic than the H3N8 virus in the mice. Contrary to this, based on field observations 
it is hypothesized here that the H7N7 virus is less virulent than the H3N8 virus in its 
natural host, the horse, during experimental infection. To this end, influenza virus 
infection was documented in all the horses by recovery of virus from nasal swab extracts 
tested in 10-day-old eggs. Viral shedding persisted in individual animals through day 6 
p.i. and no viruses were isolated from them from day 7 post challenge onwards. On day 2 
p.i., which is expected to be the day of peak virus shedding, the H7N7 virus titer was 4.49 
± 1.69 log10 EID50/ml while at the same day the H3N8 virus titer was 3 ± 1.35 log10 
EID50/ml (mean ± SD). The H3N8 virus titers of day 1 and from day 3 to day 6 p.i. were 
not determined. There was no significant difference between the two viruses in the 
duration and amount of virus excreted on day 2 p.i. (Figure 3.6). 
Clinical outcome of the horses 
Both groups displayed increases in rectal temperature after challenge infection 
with a peak on day 2 p.i. (p<0.05 for the H7N7, p≤0.001 for the H3N8), which then 
subsided after that day (Figure 3.7). But, rectal temperatures induced by the H3N8 virus 
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were significantly higher than those by the H7N7 virus on days 2 (p<0.001), 3 (p<0.05) 
and 5 post infection (p<0.05). Specifically, 4 out of 6 horses infected with the H7N7 
virus had pyrexia (>38.9 °C) on day 2 p.i. But after that, fever was absent in all except on 
days 7 and 8 p.i. At those times the four horses had increased rectal temperature as the 
consequence of hyperventilation caused by the reaction to the DORMOSEDAN® 
(detomidine hydrochloride, Pfizer Animal Health, West Chester, PA), which was 
administered intravenously to horses as a sedative before nasal tampon sampling. 
Therefore, statistical analysis was not applied for both groups since day 7 p.i. onwards. 
All animals in the H3N8 group developed fever on day 2 p.i. (40.65 ± 0.66 °C). Pyrexia 
was still present in some horses until day 8 p.i. There was a clear difference between the 
two groups regarding clinical signs, with statistical significance reached on days 4, 5 and 
6 p.i. (p<0.001) (four horses in the H7N7 group were administered medication from days 
7-14 affecting their clinical signs, therefore statistical analysis was not run for that period 
of time) (Figure 3.8). Mild clinical signs observed after day 3 p.i. among only two horses 
in the H7N7 group. In striking contrast, obvious illness persisted in all horses infected 
with the H3N8 virus from day 4 to day 9 p.i. 
Cytokine transcription response in the horses 
The mRNA expression levels of IFN-γ, IL-1β, IL-6, IL-8, IL-10, IL-18, TNF-α 
and Mx genes in individuals during the course of infection were quantified relative to the 
average level of each respective gene for all subjects within the same group on day 0 p.i. 
(Figure 3.9). Because the values of squared correlation coefficient and/or PCR 
amplification efficiency for the cytokine IFN-γ didn’t fall within the range set by LinReg 
analysis, many samples from the H7N7 group animals were excluded from further 
44 
analysis and the resulting underrepresented data from this group were not subject to 
statistical evaluation. Specifically, 4 samples were identified as outliers on day 1 p.i. 
After that day, the number of outliers decreased to one on day 2 p.i. Between days 3-5 p.i., 
no more than 3 samples were excluded from the statistical evaluation. In contrast, only 
two samples from the H3N8 group were identified as outliers (1 sample on day 0 and day 
1 p.i., respectively). However, statistical analysis revealed that the H3N8 virus infection 
failed to induce robust gene transcription of IFN-γ in the blood. Similarily, TNF-α gene 
expression was not significantly enhanced in either group following the infections, 
although 1 horse in the H7N7 group and 2 horses in the other group showed more than 3-
fold increase over the basal level. Both viral infections induced increases in the 
production of IL-1β mRNA transcripts as the level on day 2 was significantly higher than 
that on days 0 and 1 p.i. in the H7N7 group, and on days 2, 3 and 5 compared to the basal 
level in the H3N8 group (p<0.05, Two-Way RM ANOVA). Overall, however, the IL-1β 
mRNA expressions in the H7N7 group were not significantly different from the levels in 
the H3N8 group. The transcription of proinflammatory IL-6 gene was significantly 
induced by H7N7 virus infection not H3N8 virus infection except in one horse, and the 
increase in the mRNA expression occurred on day 2 p.i. (p<0.05, Friedman RM ANOVA 
on Ranks) and then subsided thereafter (p<0.05, day 2 compared to days 4 and 5 p.i.). 
However, on that day, no significant difference in IL-6 mRNA relative expression levels 
between the two viruses was observed (Mann-Whitney Rank Sum Test). Specifically, 5 
out of 6 horses in the H7N7 group demonstrated more than a 10-fold increase in IL-6 
mRNA expression on day 2 p.i. In contrast, only one animal had a similar increase in IL-
6 mRNA abundance at that time point in the H3N8 group. As a major chemoattractant for 
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neutrophils, chemokine IL-8 mRNA peripheral expression levels in both groups were 
virtually unchanged during the course of infection, except that one horse in the H3N8 
group demonstrated remarkable augmentation in the transcription level of this gene on 
day 2 p.i. compared to the calibrator. Neither the H3N8 nor H7N7 virus infection induced 
a significant enhancement in the transcription of anti-inflammatory cytokine IL-10 gene 
in the blood throughout the experiment (Friedman RM ANOVA on Ranks), although two 
out of four animals in the H3N8 group showed a large increase in this gene’s mRNA 
expression on day 2 p.i. over the basal level. On the same day, however, the Mann-
Whitney rank sum test revealed that the median of IL-10 levels in the H3N8 group was 
significantly greater than that in the H7N7 horse population (p<0.05). The peripheral 
blood mRNA levels of IL-18 in the H7N7 group remained consistently low for the 
duration of the study. In contrast, the H3N8 virus infection induced significant 
upregulation of this gene’s transcription, as 2 out of 4 animals in the group showed more 
than 10-fold increase in the mRNA level over the baseline level on days 2, 3 and 5 p.i. 
The most pronounced differences in the IL-18 transcription levels between the two 
groups also emerged at these time points (p<0.05, Two-Way RM ANOVA). As for a 
quick reference, another dot plot was created to represent coordinated expression of 
different cytokines in individual horses in temporal sequence (Appendix C). Both viruses 
induced a dramatic increase in the anti-viral Mx gene transcription on day 2 p.i. (p<0.05, 
Friedman RM ANOVA on Ranks). However, it needs to be pointed out that the Mx 
mRNA production of one animal from the H7N7 group was virtually unchanged during 
the course of infection. In the group of the H7N7-infected horses, the expression of IFN-
stimulated Mx gene correlated with the virus replication (correlation coefficient=0.48, 
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p<0.05), which was also correlated with the febrile response (correlation coefficient=0.35, 
p<0.05) (Figure 3.10). Among all cytokines examined here, only the IL-6 expression 
profile was found to correlate with the febrile response in the H7N7 group (correlation 
coefficient=0.42, p<0.05). In contrast, all inflammatory mediators except IFN-γ 
demonstrated a close correlation with the febrile development in the H3N8 group (for 
instance, correlation coefficient for IL-1β and IL-10 was 0.82 and 0.73, respectively.) 
Equine PBMCs failed to produce progeny virus after exposure to influenza virus in 
vitro 
The permissiveness of equine PBMCs to influenza virus infection was first tested 
since PBMCs can easily be obtained compared to macrophages and they play an 
important role in host immune defense against various pathogen infections. Exposure of 
equine PBMCs from a blood donor to equine influenza viruses of the H7N7 and H3N8 
subtypes did not result in an increase in progeny virus titers, which indicates that equine 
PBMCs cannot support the productive replication of influenza virus (Figure 3.11). 
Similar results were obtained when the experiment was repeated in PBMCs from three 
more different horses (data not shown). To confirm the results above, the 
immunofluorescent staining technique was subsequently employed to examine whether 
the translation of viral proteins occurred inside the host cells. The viral nucleoprotein 
(NP) protein was chosen as the target of monoclonal antibody used in this technique 
because it is the major structural protein and highly conserved among influenza A 
viruses. Nearly the entire cell population was negative for the expression of NP protein 
except for only a couple of positive signals in the whole slide (Figure 3.12). The 
occurrence of sporadic signals may be due to the presence of myeloid dendritic cells in 
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exceedingly small quantities in blood.  Primary blood myeloid dendritic cells from 
humans are found to be permissive to influenza virus infection [183-184].   
Equine blood monocyte-derived macrophages are highly susceptible to influenza virus 
infection 
On day 0, blood monocytes were homogeneously small with round shape (Figure 
3.13A). Over 7 days in culture the monocytes differentiated into mature macrophages, 
which were enlarged heterogeneous cells with cytoplasmic projections (Figure 3.13B). 
Cytochemical analysis revealed that virtually the whole population of cells was positive 
for non-specific esterase staining (Figure 3.14). The esterase enzyme is primarily present 
in monocytes and macrophages but absent in granulocytes [182]. To determine whether 
ex vivo-differentiated macrophages were permissive for influenza virus infection, 7-day-
cultured equine macrophages were infected with either the H7N7 or H3N8 virus at a 
multiplicity of infection of 5 EID50 units per cell. Both viruses exhibited similar 
replication kinetics from 0-36 hours p.i. (Figure 3.15). Viral nucleoprotein was detected 
by indirect fluorescence staining. As shown in Figure 3.16, the vast majority of cells were 
infected with either virus by 12 h.p.i., thus indicating that equine primary macrophages 
are highly efficient in supporting influenza virus infection. Productive viral infection of 
macrophages resulted in cytopathic effect (CPE) and morphological changes, such as cell 
rounding and detachment, were visually evident by light microscopy as early as 12 h.p.i. 
At 18 h.p.i. about 50% of cells detached from culture flask and complete cell detachment 
happened by 24 h.p.i. 
 No CPE or morphological alterations were observed in macrophages after 
treatment with UV-inactivated viruses, suggesting that virus replication is necessary for 
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CPE induction. The effect of monocyte differentiation stage on virus replication was also 
investigated. Infection of day-0-monocytes with equine influenza virus showed no 
detectable increase in virus titer over 24 hours incubation. In contrast, productive 
infection was noticed from day-3-cultured cells with day-7-cultured cells being highly 
permissive to the infection as the cells differentiated from precursor monocyte to mature 
macrophage (Figure 3.17). 
Infection of macrophages by equine H7N7 influenza virus resulted in TNF-α protein 
expression 
TNF-α is a major inflammatory cytokine in the pathogenesis of influenza. Levels 
of soluble TNF-α protein in culture supernatants from either the H7N7 virus-infected or 
mock-infected macrophages were analyzed by ELISA. Infection with influenza virus 
resulted in activation of equine primary macrophages as evidenced by the significantly 
enhanced expression of TNF-α protein compared with the mock infected cells at 18 hours 
p.i. (p<0.05) (Figure 3.18).  
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Table 3.1 The cDNA-deduced amino acid sequence of the HA cleavage site 
 
Virus Cleavage site 
Influenza A/equine/New York/49/73 
(H7N7) 
Q L T H H M R K K R * G L F G 
Influenza A/equine/Kentucky/5/2002 
(H3N8)a 
M R N V P E K Q I  R *  G I T G 
a : The HA cleavage site amino acid sequence of the H3N8 virus was obtained from Gene 
Bank (Accession ID:  AY855341)  
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Figure 3.1 Body weight loss rate and survival rate of BALB/c mice. Groups of 6 mice 
were inoculated intanasally with 106 EID50 units of each virus. (A) Mice were 
weighed daily, and the percentage of body weight loss was calculated relative to the 
starting weight at day 0 before virus inoculation. Data are expressed as mean ± SD. 
(B) survival rate in each group over time.  
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Figure 3.2 Virus titers in mouse lungs and brains. Mice were inoculated intranasally 
with 106 EID50 units of either H7N7 or H3N8 virus. 5 mice per virus were euthanized 
daily, and brains and BALs were collected. Virus titers in tissues were quantified in 10-
day-old eggs by EID50 assay. (A) lung. (B) brain (H3N8 virus was not detected in 
brain tissues except in one mouse on day 2 and day 5 p.i., respectively). Results are 
expressed as mean ± SD.  * indicates P< 0.05, + indicates P< 0.001 
* * 
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Figure 3.3 Quantification of cytokine and chemokine protein levels in the BALs. 
Mice were inoculated intranasally with 106 EID50 units of either the H7N7 or H3N8 
equine influenza virus. BALs of 5 mice per group were used to determine the levels of 
cytokine and chemokine by Cytometric Bead Array as described in the methods. The 
expression levels of IFN-γ, IL-6, MCP-1 and TNF-α in the H3N8 group were below the 
detection limit of the assay. Samples with undetectable levels of the respective cytokines 
were valued as 0. Data of IL-10 are presented as mean ± SEM. * indicates P< 0.05 
(Mann-Whitney Rank Sum Test).  
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Figure 3.4 Correlation of virus replication and the expression of cytokines in the 
H7N7 mice. Mice were inoculated intranasally with 106 EID50 units of the H7N7 equine 
influenza virus. BALs of 5 mice per group were used to determine the levels of TNF-α 
and IL-10 by Cytometric Bead Array as described in the methods. Virus titers in the 
BALs were quantified in 10-day-old eggs by EID50 assay. All values were log10-
transformed and presented as mean ± SEM. Virus titer (log10 EID50/ml). Cytokine level 
(log10 pg/ml). Correlation analysis was performed by Spearman Rank Order Correlation. 
Virus replication/TNF-α (correlation coefficient=0.49, p<0.05). Virus replication/IL-10 
(correlation coefficient=0.5, p<0.05). 
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Figure 3.5 Cumulative mortality rates in different-aged chicken embryos. 7 (A), 9 (B) 
and 11-day-old (C) eggs were inoculated with either the H7N7 or H3N8 equine influenza 
virus at three different log10 virus doses. Cumulative mortality rates at indicated days post 
infection were recorded. Experiment was repeated three times, and data were expressed as 
mean ± SD. * indicates P< 0.05, + indicates P< 0.001 
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Figure 3.6 Viral shedding in horses challenged with equine influenza virus. 6 horses 
were challenged with the H7N7 virus, and 4 horses were challenged with the H3N8 virus. 
Nasal swabs were collected daily post challenge. Virus isolation was performed in 10-
day-old chicken eggs. Results are expressed as Mean ± SD. (virus shedding of day 1 and 
from day 3 to day 6 for H3N8 group were not determined).  
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Figure 3.7 Daily rectal temperatures in horses. Mean ± SD. Temperature > 38.9 0C was 
regarded as pyrexia. At days 7 and 8 p.i. four horses from the H7N7 group had increased 
rectal temperature as the consequence of hyperventilation caused by the reaction to the 
DORMOSEDAN® (detomidine hydrochloride). Therefore, statistical analysis was not 
applied for both groups since day 7 p.i. onwards. * indicates P< 0.05, + indicates P< 
0.001      
* * + 
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Figure 3.8 Mean clinical scores in horses challenged with equine influenza virus. 
Each horse was examined daily for clinical signs associated with equine influenza, 
including coughing, nasal discharge, depression and anorexia.Severity of clinical 
symptoms was assessed according to a clinical scoring system (Table 2.2). Total clinical 
scores were then calculated for each animal. Values were expressed as Mean ± SD. 
Statistical analysis was not run for days 7-14. + indicates P< 0.001     
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Figure 3.9 Relative mRNA expressions of cytokine and anti-viral Mx genes in 
peripheral blood cells. 6 horses were challenged with the H7N7 virus, and 4 horses 
were challenged with the H3N8 virus. Peripheral blood was collected and processed for 
RNA isolation and cDNA synthesis. Relative quantification of the respective mRNA 
transcripts to the calibrator was performed by real time PCR. Samples marked as the 
outliers for PCR efficiency and/or correlation coefficient by LinReg program were 
excluded from further statistical analysis. $ indicates that significant difference in the 
respective cytokine was observed between the two viruses on that time point (p< 0.05). 
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Figure 3.10 Correlation of virus replication, febrile response and relative 
quantification of Mx mRNA in the blood in horses following the H7N7 virus 
challenge. Horse experimental infection with the H7N7 virus, quantification of virus 
shedding and real-time PCR analysis of Mx gene transcription were carried out as 
described in the methods. Values of virus titers and Mx gene mRNA levels were log10-
transformed. All data was presented as mean ± SD. Temperature > 38.9 0C was regarded 
as pyrexia. 
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Figure 3.11 Nonproductive replication of equine influenza virus in primary equine 
PBMCs. Freshly isolated, unstimulated equine PBMCs were inoculated with either the 
H7N7 or H3N8 virus at a multiplicity of infection of 5 EID50 units per cell. At 0 and 24 
hours post inoculation, cell supernatants were collected for infectious virus titration on 
10-day-old chicken eggs. The results were from the same horse blood donor and are 
representative of three different horses with similar results.  
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Figure 3.12 Detection of viral nucleoprotein (NP) in equine PBMCs by 
immunofluorescence microscopy. Fresh, unstimulated equine PBMCs were 
inoculated with either the H7N7 or H3N8 virus at a multiplicity of 5 EID50 units per 
cell. At 12 h.p.i. cells were collected and stained for viral NP protein (green) with 
Evan’s blue (red) as a counterstain for cytoplasm. Magnification 40 ×.  
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Figure 3.13 Morphology of monocytes and differentiated macrophages. Phase-contrast 
light microscopy. Magnification 100 ×. (A) day 0 culture, homogeneous population of 
small round monocytes. (B) day 7 culture,  heterogeneous larger cells with cytoplasmic 
projections.    
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Figure 3.14 Cytologic demonstration of non-specific esterase activity in 7-day 
cultured macrophges. Cells were processed for cytochemical staining of α-naphthyl-
acetate esterase, which is present in monocyte/macrophage lineage. Esterase-positive 
macrophages were identified due to their black granulation. Magnification 40 ×  
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Figure 3.15 Productive replication of equine influenza virus in 7-day-cultured 
macrophages. Cells were infected with either the H7N7 or H3N8 virus at a multiplicity 
of infection of 5 EID50 units per cell. Titration of infectious virus was performed on 10-
day-old chicken eggs. Mean ± SD of blood from 3 different horses.  
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Figure 3.16 Detection of viral nucleoprotein (NP) in macrophages by 
immunofluorescence microscopy. 7-day-cultured macrophages were infected with 
either the H7N7 or H3N8 virus at a multiplicity of 5 EID50 units per cell. At 12 h.p.i. 
cells were collected and stained for viral NP protein (green) with Evan’s blue (red) as a 
counterstain for cytoplasm. Magnification 40 ×.  
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Figure 3.17 Replication of equine influenza virus in different-aged monocyte-
derived macrophages. Day-0, 1, 3, 5, 7 cultured cells from the same horse were 
infected with the H7N7 virus at a multiplicity of infection of 5 EID50 units per cell. 
Cell supernatants were collected at 0 and 24 hours p.i. for virus titration on 10-day-old 
embryonated chicken eggs.  
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Figure 3.18 TNF-α production by equine primary macrophages in response to 
influenza virus infection. 7-day-cultured peripheral monocyte-derived macrophages 
were either mock infected or infected with the H7N7 virus. Cell supernatants were 
collected at indicated times for TNF-α protein quantification by ELISA. The results 
are the means ± SD of cells from three different horses. * indicates P<0.05 
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CHAPTER FOUR 
Discussion 
The primary interest of this dissertation was to decipher the determinant(s) for the 
differential pathogenicity of the equine H7N7 virus in its natural host and the BALB/c 
mouse model, and to address whether inflammatory cytokine responses are involved in 
this characteristic of this virus. A prerequisite of influenza virus infection of airway 
epithelial cells is the interaction between the HA protein and the corresponding cell 
surface receptor containing a terminal sialic acid residue (sialyoligosaccharides) [185]. 
These residues are bound to glycans through α 2,3 or α 2,6 linkage that are distributed in 
a cell- and species-specific manner [186]. For example, human tracheal epithelial cells 
present mostly α 2,6 linkage [187], while equine and mouse respiratory tracts express 
predominantly α 2,3 linkage [188-189]. Influenza viruses differ in their preference for 
recognition of sialic acid-galactose linkages. Studies show that the avian and equine 
influenza strains bind preferentially the α 2,3 linkage [188, 190], while the human viruses 
favor the α 2,6 linkage [190]. Surprisingly, human influenza viruses can still efficiently 
infect knock-out mice that lack α 2,6 linkages in the respiratory tract [191]. Taken all 
together, mouse airway epithelial cells are potentially susceptible to all strains of 
influenza A virus.  
Tissue tropism of the two viruses in BALB/c mice 
In concert with this, the current mouse challenge study showed that both equine 
H7N7 and H3N8 viruses exhibited a high degree of replication fitness (>103.5 EID50/ml 
at day 2 p.i.) in the lungs of mice without prior adaptation after intranasal inoculation, but 
produced contradictory clinical outcomes. This observation is in good agreement with a 
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previous study [167]. The equine H3N8 virus infection in BALB/c mice was 
asymptomatic and the virus was isolated almost exclusively from the lungs among 
various organs tested. In contrast, the equine H7N7 virus was isolated from the brains as 
well as the lungs of infected mice. This demonstration is clearly distinguishable from a 
previous study [167] in which a different isolate of equine H7N7 influenza virus was 
recovered from the brain on rare occasions. However, this is not surprising, considering 
that the heterogeneity of organ tropism has also been documented for various isolates of 
avian H5N1 virus as well as H7N7 virus [97, 107, 109].  
Neurotropism has also been observed in mice intranasally infected with some 
isolates of highly pathogenic avian H5 and H7 influenza viruses [106, 171, 192]. These 
viruses reached the brain along the vagus and/or trigeminal nerves following intranasal 
instillation [171, 192]. In addition, a mouse-adapted equine H7N7 isolate was shown to 
invade the brain by a similar route [193]. The proteolytic cleavage of the HA protein is a 
prerequisite for virus infectivity and spread, and hence is a primary determinant for the 
pathogenicity of influenza viruses [34]. The HA cleavage sites of avian H5 and H7 highly 
pathogenic viruses contain multibasic amino acids, which are therefore theoretically 
susceptible to cleavage by ubiquitous host subtilisin-like proteases, resulting in systemic 
infection in the host. In contrast, avirulent strains with monobasic cleavage sites can only 
be activated by proteases such as trypsin and plasmin, which are found specifically in 
cells from the respiratory or intestinal tracts, or both, and thus cause non-systemic 
infections [31, 194]. The present study confirmed the presence of multiple basic residues 
at the cleavage site in the H7N7 virus used here, whereas the H3N8 virus lacks this 
property (Table 3.1).  
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Increasing evidence indicates, however, that the highly cleavable HA is 
necessary, but not sufficient, to confer these viruses with neurovirulence in mice. It is 
generally accepted that neurotropism in mice should be attributed to a constellation of 
genes although numerous studies point to an important role played by polymerase genes 
[110, 171, 195-196]. In particular, some amino acids at specific positions (e.g. the lysine 
residue at position of 627 in PB2) have been demonstrated to be critical in controlling 
viral polymerase activity. Therefore, this molecular feature is believed to provide a 
growth advantage to the virus and to be responsible for tissue tropism [197-199]. To this 
end, a survey of the amino acid composition at residue 627 in PB2 protein was carried 
out for two representative strains of the equine H7N7 subtype and the H3N8 virus used in 
this dissertation. As a result of the comparison, a glutamate rather than lysine residue was 
found to be present at this specific position in PB2 protein of the equine H7N7 and H3N8 
viruses examined here (Appendix D). It has been recognized that a single substitution of 
glutamate for lysine at position of 627 in PB2 is a critical determinant for neurotropism in 
mice [196, 200]. Moreover, as for PB2 protein sequence homology, each of the two 
H7N7 viruses shares 99% amino acid identity with the H3N8 virus. As a matter of fact, 
the H7N7 viruses had acquired the internal gene segments (i.e. NP, NS, PA, PB1 and 
PB2) from the H3N8 viruses as the consequence of genetic reassortment between the two 
subtype viruses while they co-circulated circa 1970 [18, 20-21]. Taken together, the 
findings from this study suggest that multiple factors are involved in the neurovirulence 
of the equine H7N7 virus in BALB/c mice, and that PB2 is not a critical determinant.  
The current observation justifies an important role played by the internal genes of 
influenza virus for the mouse brain invasion since the two equine H7N7 virus strains used 
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in the present investigation and  that previous study [167] are the same for the HA/NA 
serotype and HA cleavability. Neurotropism has been proposed to account for higher 
lethality in mice infected with highly pathogenic avian H5N1 influenza viruses [171, 
201]. However, this may not be necessarily applied to equine H7N7 viruses. The two 
isolates of equine H7N7 viruses used in the current study and the previous one [167] 
induced 100% mortality rates despite having distinct organ tropisms. It is therefore 
concluded based on the present findings that invasion of the brain may not contribute 
significantly to the disease outcome of mice infected with equine H7N7 viruses.  
Inflammatory responses induced by the viruses in BALB/c mice 
The work reported here demonstrated indirectly that the two virus subtypes had 
differential capacities to affect the innate immunity of the BALB/c mouse. This 
distinction between the two viruses suggests that a comparable difference might be seen 
in the pulmonary cytokine expression levels since cytokines are known to be the integral 
mediators of the immune responses. To this end, quantification of temporal changes in 
cytokine abundances in a sequential manner during the course of infection was 
performed. The production levels of pulmonary cytokines and chemokine studied here in 
the H7N7-infected mice appear to reach maximum in the late phase of infection (on day 6 
p.i.) (Figure 3.3). However, statistical evaluation didn’t provide solid support for that 
trend. Nevertheless, a previous study showed that expression levels of pulmonary 
cytokines/chemokines peaked on day 5 after infection with the highly pathogenic avian 
H5N1 influenza virus in mice [111]. A great deal of variation in the absolute quantity of 
cytokine produced was noticed among individual mice of the H7N7 group, which 
resulted in the large standard deviations in Figure 3.3. Despite the high genetic 
homogeneity of inbred mice, mouse-to-mouse variation in response to stimulus or 
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treatment within the same strain has been commonly observed [202-204]. In this study, 
such substantial intersubject variation was unlikely to be due to the degree of virus 
replication (Figure 3.2), and instead may be attributed to the intrinsic interanimal 
variability in the immune response dynamics [202] to the virus or to considerable 
individual differences in the response of inbred mice to social stress arising among cage 
mates during group housing. Social and psychological stress are known to have a direct 
impact on immune responses to infection in humans as well as various animals [205]. 
And moreover, the small number of animals (n=5) employed here could make that 
mouse-to-mouse variation more visible [204].  
Among the cytokines studied here, IL-6, as one of the principal proinflammatory 
cytokines in the pathogenesis of influenza [206], does not contribute significantly to the 
avian H5N1 virus lethal infection in mice [113, 207]. Another critical mediator in the 
inflammation, TNF-α, has been shown to have deleterious effect on the disease 
progression [113, 208]. Gene-knockout analysis targeting the TNF-α receptor in a mouse 
model provided the latest evidence that TNF-α signaling is more important in regulating 
the pathogenesis of the highly pathogenic influenza virus infection [209]. In fact, the 
present investigation showed that among several proinflammatory cytokines, only the 
TNF-α response correlated with the H7N7 virus replication in the mouse lung.  
An array of chemotactic cytokines, such as monocyte chemoattractant protein 
(MCP-1), macrophage inflammatory protein (MIP-1α/β) and IL-8, are secreted rapidly by 
respiratory epithelial cells and resident tissue macrophages underneath the infected 
epithelial layers during the acute phase response to primary influenza virus infection. 
These chemokines promote massive leukocyte trafficking from the circulation to sites of 
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inflammation, which are crucial requirements for the subsequent cell-mediated viral 
clearance [210]. MCP-1 is a predominant chemotactic factor responsible for the 
recruitment of macrophages and neutrophils, and blockade of MCP-1 function by 
antibody treatment dramatically reduced leukocyte influx into the lungs after influenza 
virus infection in mice, and consequently resulted in enhanced lethality [211]. However, 
the present findings showed that the expression of pulmonary MCP-1 was below the 
detection limit in almost all mice infected with the H7N7 virus before day 6 p.i. This 
might be due to the relatively high detection limit of the assay applied here (52.7 pg/ml 
for MCP-1). Nevertheless, a previous investigation has already demonstrated that the 
quantity of MCP-1 present in mouse lungs was directly proportional to the numbers of 
pulmonary cellular infiltrates following intranasal inoculation of mice with the highly 
pathogenic avian H5N1 influenza virus infection [212]. The increased presence of these 
immune cells in the mouse lung assists in limiting the virus replication [213]. Meanwhile, 
however, the excessive accumulation of infiltrated inflammatory immune cells has been 
demonstrated to contribute to pulmonary inflammatory pathology [213-214].  
IFN-γ is a proinflammatory cytokine with well-characterized antiviral activity and 
many other functions involved in the adaptive immunity including augmentation of major 
histocompatibility complex (MHC) expression and stimulation of T and natural killer 
(NK) cells [206]. However, efficient viral clearance or humoral and cellular responses 
during primary influenza A virus infection in mice is not dependent on IFN-γ, and it 
rather acts as a typical proinflammatory mediator by regulating leukocyte recruitment 
into the inflamed site during the acute phage of infection [215-218]. Indeed, in this study 
the detectable expression of this cytokine was recorded in the lungs of most mice infected 
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with the H7N7 virus whereas the expression of IFN-γ was beyond the detection limit of 
the assay in all mice from the H3N8 group.  
IL-10 is a potent anti-inflammatory cytokine that inhibits the synthesis of TNF-α, 
IL-1, and IL-6 by monocytes and macrophages [219-220]. For the fatal avian H5N1 virus 
infection, high levels of IL-10 expression were detected in humans [95] and mice [221]. 
Consistent with previous studies, higher IL-10 protein concentrations in the H7N7 virus-
infected mice compared to those in the H3N8 virus group were observed in the present 
study. As an endogenous antagonist to the pro-inflammatory cytokines [222], the 
production of IL-10 is believed to offer feedback inhibition in limiting uncontrolled 
inflammatory responses in mice with lethal avian H5N1 infection [221].  
IL-12 is primarily produced by monocyte-macrophages and has a role in the early 
innate immune defense against primary influenza virus infection in BALB/c mice [166]. 
During influenza virus infection in mice, the level of its pulmonary production was 
reported to be low [166, 223]. Here, neither of the two viruses induced a detectable IL-12 
expression in the lungs of mice at any time point tested in the present report. 
Although an exaggerated cytokine response is widely believed to be one of major 
contributors to the severe pathogenesis of avian H5N1 influenza and 1918 pandemic 
influenza, debate continues as to whether the unusual severity of the disease associated 
with avian H5N1 viruses is the consequence of dysregulated immune response or instead 
is caused by the intrinsic pathogenicity of the virus itself [113, 207]. The later argument 
is exemplified by the extraordinary replication efficiency of a particular influenza A virus 
strain (generated by serial lung passages of A/PR/8/34 (H1N1) virus in Mx-competent 
mice), which has been shown to overrun the innate immune defense response and thereby 
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endow it with high virulence in mice [224]. Specifically, high viral loads have been 
reported in the avian H5N1 virus infection in humans and mouse models as well [95, 107, 
111]. The present study showed that the equine H7N7 viral loads in the lungs of mice 
were significantly greater than the H3N8 viral loads after day 2 p.i. until the death of 
those mice. It is therefore tempting to speculate that the equine H7N7 influenza virus was 
resistant to the initial host immune control, thus leading to a remarkable viral burden, 
which in turn drove an overwhelming inflammatory response, and all of these 
characteristics contributed to the lethal outcome of the equine H7N7 influenza virus 
infection in BALB/c mice. We can derive from this that the key of successful therapeutic 
treatment during highly pathogenic influenza virus infection is the blockage of 
uncontrolled virus replication by timely administration of antiviral medication first, and 
combined with alleviation of over-exuberant immune responses if necessary.  
Pulmonary hemorrhage in the mice caused by the virus infection 
Large amounts of erythrocytes in the lung lavage fluids were noticed in the later 
stages of the equine H7N7 virus infection in mice, which implied the the occurrence of 
lung hemorrhage. Pulmonary hemorrhage was also observed by histopathological 
examination in some cases of avian H5N1 infection in humans [94, 98] and in a mouse 
model [225]. Hemorrhage is the consequence of destruction of vascular integrity and 
subsequent increase in permeability. Two contributory mechanisms are currently known 
to be responsible for vascular damage. The first one is the direct cytotoxic effect of virus 
replication within vascular endothelial cells. Human influenza virus was shown to be able 
to infect human endothelial cells in vitro [226]. In some severe cases of influenza in 
children, viral antigen was detected in endothelial cells in vivo [227]. Moreover, certain 
isolates of highly pathogenic H5N1 avian influenza virus were found to target vascular 
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endothelial cells of domestic chickens [228-229] and wild birds [230-231]. A particular 
highly pathogenic strain of the H7N1 subtype predominantly attacked endothelial cells in 
all organs of chicken embryos [232]. In this regard, it is desirable to investigate whether 
equine H7N7 influenza virus can infect vascular endothelial cells of the chicken and 
mouse in the future studies.  
Second, prominent dysregulation of host inflammatory responses may be a 
mechanism for vascular damage. Inflammation is an orchestrated series of events that 
must be elaborately regulated to facilitate host recovery from infection. Any event that 
disrupts this carefully balanced process may have a deleterious impact on the host [11, 
233-235]. Data from this dissertation showed that the equine H7N7 influenza virus 
infection triggered a heightened potent expression of pulmonary inflammatory cytokines 
compared to the H3N8 virus in BALB/c mice. As discussed above, each of these 
cytokines has its specific function yet also overlapping activity with other cytokines. 
Compelling evidence has demonstrated that exacerbation of inflammatory cytokine 
responses may impose injury to endothelial function [236]. In particular, TNF-α is a 
major mediator of the endothelial system, causing vasodilation and increased vascular 
permeability [162]. Therefore, intense expression of inflammatory cytokines observed in 
this study may contribute to the development of pulmonary hemorrhage in BALB/c mice 
infected by the equine H7N7 influenza virus.  
Chicken embryo innate defense against the viral infections 
Embryo age at the time of inoculation has been known to influence the non-
specific innate immunity against virus infection [237]. The innate immune system 
develops functionally during embryogenesis, as does the interferon system, which may 
account in part for the age-dependent mortality [237-238]. Interferons are well known for 
87 
their antiviral activities. Once induced after virus infections, they mount powerful 
antiviral responses through the action of downstream IFN-induced effector genes [129]. 
Previous studies, however, showed that highly pathogenic avian H5N1 influenza viruses 
compared with the less virulent ones possess the outstanding capacity to counteract the 
interferon system probably by suppressing the production of IFNs [239-240], or by 
downregulating the signaling pathway required for the induction of IFN-stimulated genes 
[241], or most likely even both in vivo. The present investigation demonstrated that the 
action of chicken embryo innate immunity, which was probably led by the interferon-
induced antiviral system, failed to restrain cytopathic effect of the equine H7N7 virus. To 
test this possibility, future work including quantification of IFN production and virus 
replication in IFN-pretreated and non-treated cell lines as well as in embryos following 
inoculation is warranted.  
Inoculation of the allantoic cavity of embryonated chicken eggs aged 10 or 11 
days old is the primary route for propagation of influenza virus in laboratory settings. In 
11-day-old eggs, cytopathic effect of the H7N7 virus but not the H3N8 virus likely 
spread beyond the allantoic compartment, which, therefore, could explain the highly 
virulent phenotype of the H7N7 virus in chicken embryos observed in the present study. 
Certainly, high cleavability of the HA protein enables the H7N7 virus to acquire extended 
tissue tropism. Furthermore, a previous study clearly demonstrated that a highly 
pathogenic avian influenza virus of the H7 subtype with highly cleavable HA induced 
systemic infection in 11-day-old chicken embryos [232]. It is worthy to note that the 
maximal cumulative mortality rates recorded for 11-day-old eggs occurred at day 5 after 
infection with high doses of the H7N7 virus (Figure 3.5C). Therefore, cytopathic effect of 
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the H7N7 virus in chicken eggs cannot affect the process of the virus amplification, 
which, as described in the Materials and Methods, needs 2 days of incubation following 
inoculation with the seed virus. 
Horse inflammatory responses induced by the viral infections 
 Both viral infections in horses remained well controlled by the host immune 
defensive responses and detectable viral clearance was successfully accomplished by day 
7 p.i., yet the H3N8 virus was more pathogenic in terms of clinical signs than the H7N7 
virus in horses. This observation fits well with previous reports [172-173]. The clinical 
severity correlated with the transcription levels of inflammatory cytokines in the 
peripheral blood, which complements a previous study that documented differential 
clinical responses in ponies challenged with H3N8 influenza virus strains of different 
pathogenicity [242].  
To study immune responses to influenza virus in the horse, cytokine 
quantification could be carried out in nasal washing fluid or lung lavage fluid to identify 
local cytokine responses to the infection, or could be measured in plasma and serum 
reflecting systemic immune response. However, a paucity of immunological reagents for 
the horse constitutes a major obstacle to better understanding of the immune system 
function in equine influenza. An alternative way to quantify the cytokine expression is 
the measurement of cytokine transcription levels by real time PCR. Some studies, 
however, have demonstrated that the processes of collection, transport and processing of 
samples could not only result in mRNA degradation [243] but also be responsible for ex 
vivo stimulation of mRNA expression [244]. The PAXgene blood RNA collection system 
was used in the present study for RNA isolation from whole blood because it offers 
several technical superiorities including immediate RNA stabilization and ease of use 
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[245]. This system was successful applied before for equine cytokine mRNA 
quantification [246].  
IL-1β, Il-6 and TNF-α have been recognized as the hallmark proinflammatory 
cytokines readily produced by macrophages/monocytes in response to influenza virus 
infection and they act in a synergistic fashion to contribute to the induction and 
development of the disease symptoms [210, 247]. Among them, only IL-6 was found to 
be directly correlated to some extent with the clinical severity of the disease, as 
extensively demonstrated in humans [248-250], pigs [251-252], horses [242, 246] and 
ferrets [253]. The present study revealed that equine influenza virus of the H3N8 subtype 
was more pathogenic than the H7N7 subtype during experimental infection in horses with 
respect to clinical manifestations and febrile reactions induced. However, it was 
unexpected that the H7N7 virus induced greater, although not significant, IL-6 mRNA 
expression in peripheral blood on day 2 post infection than the H3N8 virus did. The 
results definitely warrant further investigations of local and systemic production of IL-6 
at the protein level in the future to verify the current observation. By comparison, both 
viruses triggered a similar magnitude of transcriptional changes of TNF-α and IL-1β 
genes in whole blood despite apparent difference regarding clinical outcome. Therefore, 
the findings from the present study do not support a significant correlation between 
clinical signs and the extent of TNF-α or IL-1β released following equine influenza 
infection in horses. In a previous horse challenge study with equine H3N8 influenza virus 
[246], the transcription of the TNF-α gene was not significantly elevated in the peripheral 
blood after experimental infection. Bioassay also failed to detect the presence of TNF-α 
protein locally or systemically in ponies challenged with equine influenza virus [242]. In 
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accordance with these observations, neither of the two viruses in the present study 
induced a pronounced increase in the circulating levels of TNF-α mRNA.  
IL-8, a potent neutrophil chemotactic cytokine [254], increases significantly in 
nasal fluid and lung lavage fluid in response to influenza virus infection in humans [250, 
255] and pigs [256].  But, it is not detected at the protein level in human plasma in 
seasonal human influenza cases [250]. Likewise, neither the H7N7 nor H3N8 virus 
induced significant changes in IL-8 mRNA expression in horse peripheral blood. 
Notably, rather high levels of IL-8 in serum were observed in the fatal cases of human 
infection with highly pathogenic avian influenza viruses [95].  
IL-18, a member of the IL-1 family [257], is induced mainly in 
monocyte/macrophage cells after influenza virus infection [154]. The current data show 
that the H3N8 virus induced significantly greater IL-18 gene transcription in horse 
peripheral blood than the H7N7 virus. IL-18 was originally named as IFN-γ-inducing 
factor because of its ability to induce IFN-γ production in an antigen-independent manner 
by natural killer cells and T lymphocytes synergistically with the cofactor IL-12 [258-
259]. It has proinflammatory properties, such as induction of TNF-α, IL-1β and several 
chemokines [260]. Besides its function in regulation of inflammatory responses, IL-18 
plays an important role in directing the immune response against viral infection toward 
cell-mediated immunity. This point has been highlighted in several in vivo studies using 
mouse models, in which IL-18 was found to facilitate the host defense against influenza 
virus infection through activation of natural killer [261] and T cells [262]. The exact role 
played by IL-18 during equine influenza infection of horses merits further investigations.  
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IFN-γ is a product of activated T lymphocytes and natural killer cells after 
induction by macrophage-derived cytokines such as IL-18, IL-12 and IL-1β or pathogen 
specific stimulation via contact with an antigen-presenting cell. As a “late” mediator in 
the cytokine cascade produced in response to influenza virus infection [210], IFN-γ is 
well known for its critical role in the development and regulation of antigen-specific 
cellular immune responses to the viral infection. Enhancement of IFN-γ mRNA 
expression in equine PBMCs following in vitro re-stimulation with influenza virus was 
observed 2 weeks or even longer after experimental infection of donor equids by equine 
influenza virus [263-264]. Therefore, it is not unexpected that equine influenza viruses of 
both H7N7 and H3N8 subtypes failed to upregulate the IFN-γ gene transcription in the 
peripheral blood during the early stages of experimental infection in horses.  
In this study, compared to the H7N7 virus, the H3N8 virus infection induced 
significantly higher expression of IL-10 mRNA in the peripheral blood on day 2 post 
infection. As discussed above in the section of mouse study, IL-10 is a major anti-
inflammatory cytokine. However, information about the function of IL-10 in equine 
influenza is extremely rare. It still remains unresolved from the current investigation 
whether IL-10 actually antagonizes over-exuberant inflammatory responses during 
equine influenza virus infection in horses.  
The present horse challenge study has a major limitation in that it did not 
investigate the transcriptional levels of these cytokine genes in the lung. It is well known 
that influenza virus attacks the airway epithelial cell layer and resident tissue 
macrophages and dendritic cells situated in most proximity with it. Damage to the 
respiratory tract tissue caused by virus infection elicits a subsequent enormous migration 
92 
of leukocytes from the peripheral blood to this inflamed micro-anatomical compartment, 
which is therefore the prime site of cytokine secretion, and systemic spread of 
inflammatory mediators probably represents the “spill-over” effects [252]. Several 
previous experimental influenza studies have provided evidence to support this notion by 
showing that cytokine protein levels in the circulation are generally lower than those in 
the pulmonary compartment or are undetectable [250, 252]. In this regard, significance 
may be underestimated when interpreting the role of a particular cytokine in the 
pathogenesis of influenza based solely on the magnitude of its presence in the circulation. 
Furthermore, a caveat arises, especially when comparing the results of the present horse 
experimental infection study to other investigations on the translational expression of 
cytokines during influenza infection, which is that mRNA transcript abundance does not 
necessarily correlate with the level of encoded protein. In eukaryotes, synthesized 
mRNAs have to go through post-trancriptional processes such as mRNA splicing and 
levels are also affected by mRNA stability before producing encoded proteins [265].  
Species-specific differences in proteases 
As discussed above, the HA protein of the H7N7 virus examined in this study 
carries a multibasic motif at the cleavage site that renders the HA capable of proteolytic 
activation by ubiquitous host subtilisin-type proteases such as furin and PC6 [266]. These 
proteases display similar substrate specificities for the HA with furin being identified to-
date as the primary one in respect of cleavage efficiency in murine species [266-268]. 
Since the proteases responsible for processing of HA of equine influenza viruses in the 
horse have not been characterized, the study presented here cannot rule out the possibility 
that the differential pathogenicity of the H7N7 virus in horses and BALB/c mice is 
attributable to the intrinsic difference in host HA-activating protease profiles between the 
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two species, specifically, for instance, their predominant distribution at tissue or cellular 
levels [269] and cleavage potency [266-267] of the respective leading candidate proteases. 
Furthermore, such a difference may be further augmented during the process of the viral 
infection in vivo, as supported by the findings that influenza virus is able to facilitate its 
spread in mice by upregulating the local expression of multiple trypsin-like proteases in 
various organs tested, including the lung [270-272]. Notably, host genetic background 
has a significant influence on the differential expression of these enzymes in laboratory 
mouse strains [270]. In addition to their requirement for processing of many viral 
glycoproteins [267, 272], proteases and their target cell surface receptors are also an 
integral element of the host innate immune system against microbial infections including 
influenza virus [273-274]. This fact, in one respect, simply highlights the indispensable 
role of the immune defense system, an intricate and dynamic network of components, as 
the body’s safeguard against invading threats no matter whatever form or scale. Finally, 
the outcome of any pathological process is shaped by the overall force balance between 
the two adversaries engaged in such a war.  
The role of antiviral Mx protein in the innate immunities 
The mouse innate immunity was unsuccessful in limiting the H7N7 virus spread, 
which, however, was conquered by the horse innate immune defense. The inherent 
species-specific differences in innate immunity might be due to the absence of a 
functional Mx gene in the strain of BALB/c mouse but not in the horse [135, 138-139]. 
Nine out of ten horses tested here demonstrated inducible expression of Mx mRNA after 
influenza virus infection. A previous investigation also identified Mx protein production 
in peripheral blood mononuclear cells from some but not all horses examined [139]. 
However, it is currently unclear whether equine Mx protein has antiviral activity. Many 
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standard laboratory strains of mice (including the BALB/c mouse) are highly inbred lines 
as the consequence of systematic artificial inbreeding for specific desirable traits within 
the context of scientific research. As a double-edged sword, the deliberate inbreeding, 
leads to reduced genetic diversity, enhanced risk for certain genetic defects and 
corresponding diseases. One case for such deleterious byproducts of inbreeding is that 
BALB/c mice carrying a defective Mx gene in the genome are susceptible to influenza 
virus infection [135]. As one of IFN-stimulated genes with antiviral activity, Mx protein 
has been recognized to be the major antiviral effector against influenza virus infection in 
mice. Transgenic expression of mouse Mx protein rendered Mx-deficient mice resistant 
to not only mouse-adapted strains [275-276] but also to the pandemic 1918 and highly 
pathogenic avian H5N1 influenza viruses [277-278]. Yet, it is noteworthy to mention that 
such protection was inversely correlated with the inoculation dose. When the Mx-
competent mice were inoculated with a highly pathogenic H5N1 virus isolate at a dose of 
10 LD50 (Lethal Dose, 50%), all animals survived whereas six out of eight mice died 
when the challenge dose was increased to 100 LD50 [278]. In other words, the protective 
effect of Mx could be overcome by a higher dose of virus. 
Nevertheless, the hypothesis proposed above that Mx gene is responsible for the 
observed species-specific differences in innate immune response between the BALB/c 
mouse and the horse may not be extended to explain the similar differences between the 
horse and the chicken embryo model studied here. In spite of its presence and induction 
during influenza virus infection, Mx protein was found to be devoid of antiviral activity 
against influenza virus in the wild duck [279] and most chicken breeds tested [280-281]. 
Therefore, Mx protein is not likely to be a significant contributing factor to the innate 
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defense of the chicken embryo. However, the absence of an Mx-mediated antiviral 
element does not compromise fully immunocompetent chickens against most influenza 
virus strains except for the highly pathogenic avian influenza viruses of the H5 and H7 
subtypes. Comparably, although the BALB/c mouse strain lacks a functional Mx gene, 
the innate immunity of these mice was strong enough to defeat the equine H3N8 virus 
infection as clearly demonstrated by the present study. This innate defense could be 
compensated by the function of other IFN-induced antiviral components, such as the 
dsRNA-dependent protein kinase (PKR), the oligoadenylate synthetase (OAS)/RNase L 
system or additional still-to-be-dentified protectors. A knock-out mouse study featuring 
the triple deficiencies of PKR, RNaseL and Mx clearly revealed the existence of 
additional antiviral pathways against influenza virus [282]. No matter what molecular 
executors have been involved in the innate resistance to influenza virus in the BALB/c 
mouse and the chicken embryo, the current study has provided indirect, but compelling 
evidence that the equine H7N7 virus had an extraordinary ability to escape the host innate 
immune control, a characteristic that is reminiscent of highly pathogenic avian H5N1 
influenza viruses, which are known to circumvent the innate immune system by various 
strategies from suppressing IFN production and its JAK/STAT signaling pathway [240-
241] to directly blocking the action of antiviral effector proteins, such as PKR and 
RNaseL [283].  
Equine primary cell cultures following exposure to the viruses 
PBMCs are a heterogeneous population, composed predominantly of lymphocytes 
and monocytes. Monocytes comprise about 10% of the cell population and are adherent, 
while lymphocytes comprise about 75% and are non-adherent [284]. The current study 
showed that fresh, unstimulated equine PBMC are not a permissive cell culture for 
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influenza virus. This finding is in agreement with previous studies [285], in which 
influenza virus infection of human PBMC was abortive. Absence of viral translation 
activity demonstrated by immunofluoresent assay indicates that an early block in the 
replication cycle of virus could account for the failure of equine influenza virus 
replication. The stage of interruption does not likely occur during virus entry into cells, as 
previous studies on human PBMCs showed that lymphocytes possess surface receptors 
for influenza virus [286] and PBMC can be infected by this virus [285, 287].  
Typical characteristics of the mature macrophage phenotype were observed 
during monocyte in vitro differentiation in this study, which agree with a previous 
demonstration [288]. It has been well documented that the status of monocyte-
macrophage differentiation influences the susceptibility of macrophage to virus infections 
[289-290]. Present data show that freshly isolated equine blood monocytes were 
refractory to influenza virus infection, whereas fully differentiated macrophages were 
highly susceptible. Perhaps it is not surprising that equine influenza virus does not 
display monocyte/lymphocyte tropism since the infection by this virus is restricted to the 
respiratory epithelium and does not spread systemically [12]. In vitro monocyte 
differentiation is accompanied by upregulation of cell surface maker expression and 
phagocytic capacity in addition to the morphological changes [291], which may account 
for their increased permissiveness to equine influenza virus infection. Productive 
replication of equine influenza virus turned macrophages from inertness into activated 
status, as represented by the potent expression of cytokine TNF-α in virus-infected cells 
compared to mock-infected controls.  
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Rapid progeny virus production in mature macrophages eventually caused 
progressive cell destruction. Previous studies reported that CPE induction in cells 
infected with poxvirus or avian hemangioma retrovirus occurs regardless of viral 
replication [292-293]. To rule out the possibility that CPE may be the result of cell 
surface receptor-virus interaction, macrophages were infected with UV-inactivated 
viruses. The current results indicate the necessity of active viral replication for cell 
pathology. This is also consistent with a previous demonstration in a murine macrophage 
cell line infected with human influenza virus [294].  
In conclusion, this dissertation demonstrated for the first time that a representative 
isolate of the equine influenza virus H3N8 subtype is more pathogenic in respect of 
clinical signs than one of the equine influenza virus H7N7 subtype in horses during 
experimental infection, and the observed difference in clinical severity correlated with the 
transcription levels of inflammatory cytokines in the peripheral blood. However, both 
viral infections produced mild, non-lethal disease for their natural host, the horse. In 
contrast, the equine H7N7 virus infection is lethal for chicken embryos and BALB/c 
mice, a characteristic that is vividly reminiscent of highly pathogenic avian H5 and H7 
influenza viruses. This equine H7N7 virus had the outstanding capacity to escape the host 
innate immune control of BALB/c mice and chicken embryos, and consequently induced 
high viral loads and elevated expression of inflammatory cytokines in the lungs of 
BALB/c mice. Now there is increasing concern about the potential pandemic of avian 
influenza. The present mouse study with the equine H7N7 virus may offer a safer 
surrogate research model for dissection of the molecular basis for the unusual 
pathogenesis of highly pathogenic avian influenza viruses. Moreover, in view of the 
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striking dichotomy of virulence demonstrated by the equine H7N7 virus infection in 
BALB/c mice and horses, a thorough understanding of the viral and host determinants 
that interact to dictate the disease outcome of cross-species infections may throw light on 
the development of potential preventive and therapeutic strategies for treating humans 
threatened by highly pathogenic avian influenza viruses and by the recent global 
outbreaks of swine-origin influenza viruses. 
Future Directions 
         This dissertation clearly demonstrated that transcription of the equine Mx gene was 
greatly induced early in the course of infection. Therefore, there is an urgent need to 
ascertain whether the equine Mx protein actually exhibits inhibitory activity against 
influenza virus. If it does then the degree of sensitivity of equine H7N7 influenza virus to 
the action of equine Mx protein versus the mouse counterpart can be measured by in vitro 
test first, and a comparative pathogenesis study could be conducted subsequently by 
using a transgenic mouse model expressing an introduced mouse or equine Mx gene 
during equine H7N7 influenza virus experimental infection if the results found in the in 
vitro study show promise. This will provide a chance to test the hypothesis obtained from 
this dissertation that the discrepancy in pathogenicity of equine H7N7 influenza virus in 
two disparate mammalian species is attributable to the presence of Mx antiviral function 
in the horse but not in the BALB/c mouse. Considering that the innate immune system is 
a complicated and tightly orchestrated network of molecular and cellular components that 
interplay across various levels within the host, and equine H7N7 influenza virus has the 
ability to evade the host innate immune defense as revealed by the present study, it would 
be useful to further perform a comparative analysis of global gene expression profiling 
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between the horse and the BALB/c mouse or the chicken in the context of equine H7N7 
virus infection through a microarray platform. By virtue of such an approach, intriguing 
findings and ultimately a conclusive explanation for the observed differential 
pathogenicity of equine H7N7 influenza virus in different species may be obtained. 
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APPENDIX A:  
ABBREVIATIONS 
ANOVA = analysis of variance 
β-Gus = beta-glucuronidase 
BAL = bronchoalveolar lavage 
BALB/c = a laboratory-bred strain of the house mouse 
CPE = cytopathic effect 
CT = cycle threshold  
DCs = dentritic cells 
DNA = deoxyribonucleic acid 
EID50 = 50% egg infectious dose  
ELISA = enzyme-linked immunosorbent assay 
FITC = fluorescein isothiocyanate  
GTPases = a large group of enzymes that bind and hydrolyze guanosine triphosphate  
HA = hemagglutination test 
HA = influenza A virus hemagglutinase 
IFN-α/β = interferon alpha/beta 
IFN-γ = interferon gamma 
IL-1β =interleukin-1 beta 
IL-6 = interleukin-6 
IL-8 = interleukin-8 
IL-10 = interleukin-10 
IL-12 = interleukin-12 
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IL-18 = interleukin-18 
IP-10 = interferon gamma-induced protein 10  
IRF-9 = interferon regulatory factor 9 
ISGF-3 = interferon-stimulated gene factor 3      
Jak1 = janus kinase 1 
JAK-STAT = janus kinase-signal transducer and activator of transcription pathway 
LD50 = lethal dose, 50% 
LinReg = linear regression analysis   
M = influenza A virus matrix protein 
MCP-1 = monocyte chemotactic protein-1 
MHC = major histocompatibility complex       
MIP-1α = macrophage inflammatory protein-1 alpha 
Mx = myxovirus resistance gene/protein 
NA = influenza A virus neuraminidase 
NK = natural killer cells 
NP = influenza A virus nucleoprotein 
NS = influenza A virus nonstructural protein 
OAS = oligoadenylate synthetase 
PA = influenza A virus polymerase complex subunit A 
PB1 = influenza A virus polymerase complex subunit B1 
PB1-F2 = a protein encoded by an alternative reading frame within the PB1 gene 
PB2 = influenza A virus polymerase complex subunit B2 
PBMCs = peripheral blood mononuclear cells 
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PBS = phosphate buffered saline 
PC6 = prpprotein convertase-6 
PCR = polymerase chain reaction 
p.i. = post infection    
PKR = protein kinase R  
R2 = squared correlation coefficient  
RANTES = regulated upon activation, normal T cell expressed and secreted  
RM-ANOVA = repeated measures analysis of variance 
RNA = ribonucleic acid 
RNase L = an interferon-induced ribonuclease (Latent) 
RNP = influenza A virus ribonucleic acid-protein complex 
RT-PCR = real-time polymerase chain reaction 
SD = standard deviation   
SEM = standard error of the mean 
STAT 1/2 = signal transducer and activator of transcription 1/2 
TGF-β = transforming growth factor beta  
TNF-α = tumor necrosis factor-alpha 
Tyk2 = tyrosine kinase 2 
UTR = untranslated region in ribonucleic acid  
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APPENDIX B:  
The expression levels of multiple pulmonary cytokines in each H7N7-infected mouse 
during the assay period     
 
Notes: Since mice had to be euthanized to collect lung lavages for cytokine assay daily, 
therefore the mice used at each time point were not the same. All data was expressed as 
log10 pg/ml.  
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APPENDIX C: 
Relative quantification of several cytokine mRNAs in individual horses in the course 
of infection 
 
Note: Horses challenged with the H7N7 virus were (#85, #160, #C011, #D001, #F017, 
#F019). Horses challenged with the H3N8 virus were (#G001, #G002, #G005, #G009)  
Horse #85
Days post challenge
0 1 2 3 4 5
Re
l. E
xp
re
ssi
on
0
10
20
30
40
50
FN-γ
NF-α
IL-1β
IL-6 
IL-8 
IL-10 
IL-18 
 
Horse #160
Days post challenge
0 1 2 3 4 5
Re
l. E
xp
re
ssi
on
0
2
4
6
8
10
12
14
16
18
IFN-γ
TNF-α 
IL-1β
IL-6 
IL-8 
IL-10 
IL-18 
 
107 
 
Horse #C011
Days post challenge
0 1 2 3 4 5
Re
l. 
Ex
pr
es
sio
n
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
IFN-γ
TNF-α
IL-1β
IL-6 
IL-8 
IL-10 
IL-18 
 
 
Horse #D001
Days post challenge
0 1 2 3 4 5
Re
l. 
Ex
pr
es
sio
n
0
2
4
6
8
10
12
14
IFN-γ 
TNF-α
IL-1β
IL-6 
IL-8 
IL-10 
IL-18 
 
108 
 
Horse #F017
Days post challenge
0 1 2 3 4 5
Re
l. 
Ex
pr
es
sio
n
0
2
4
6
8
10
12
14
16
IFN-γ
TNF-α 
IL-1β 
IL-6 
IL-8 
IL-10 
IL-18 
 
 
Horse #F019
Days post  challenge
0 1 2 3 4 5
Re
l. E
xp
re
ssi
on
0
5
10
15
20
25
IFN-γ
TNF-α
IL-1β
IL-6 
IL-8 
IL-10 
IL-18 
 
109 
 
Horse #G001
Days post challenge
0 1 2 3 4 5
Re
l. E
xp
re
ssi
on
0
10
20
30
40
50
IFN-γ 
TNF-α 
IL-1β 
IL-6 
IL-8 
IL-10 
IL-18 
 
Horse #G002
Days post challenge
0 1 2 3 4 5
Re
l. E
xp
re
ssi
on
0
5
10
15
20
25
IFN-γ 
TNF-α
IL-1β 
IL-6 
IL-8 
IL-10 
IL-18 
 
110 
 
Horse #G005
Days post challenge
0 1 2 3 4 5
Re
l. E
xp
re
ssi
on
0
10
20
30
40
IFN-γ
TNF-α 
IL-1β
IL-6 
IL-8 
IL-10 
IL-18 
 
Horse #G009
Days post challenge
0 1 2 3 4 5
Re
l. E
xp
re
ssi
on
0
20
40
60
80
IFN-γ
TNF-α 
IL-1β
IL-6 
IL-8 
IL-10 
IL-18 
 
111 
APPENDIX D: 
Comparison of PB2 amino acid sequences at position of 627 of the equine influenza 
viruses 
 
virus Amino acid residue at position of 627 in PB2 
Influenza A virus 
A/equine/Cornell/16/74 
(H7N7) 
 
Influenza A virus 
A/Equine/London/1416/73 
(H7N7) 
 
Influenza A virus 
A/equine/Kentucky/5/02 
(H3N8) 
 
 
            ------F-A-A-A-P-P-E-Q-S-R-M-Q-F----- 
 
 
 
            ------F-A-A-A-P-P-E-Q-S-R-M-Q-F----- 
 
 
 
            ------F-A-A-A-P-P-E-Q-S-R-M-Q-F----- 
 
Notes:  
(1) The individual amino acid sequence of PB2 examined here was obtained from Gene 
Bank.  
(2) Influenza A virus A/equine/Cornell/16/74 (GeneBank Accession No. ACB30161.1) 
(3) Influenza A virus A/Equine/London/1416/73 (GeneBank Accession No. 
AAA43141.1) 
(4) Influenza A virus A/equine/Kentucky/5/02 (GeneBank Accession No. AAX23572.1) 
 
 
 
 
 
 
 
 
 
112 
REFERENCES 
 
1. Kawaoka Y, Cox NJ, Haller O, Hongo S, Kaverin N, Klenk HD, Lamb RA, 
McCauley J, Palese P, Rimstad E et al: Index of Viruses - Orthomyxoviridae. 
In: ICTVdB. New York: Columbia University; 2006. 
2. Wright PF, Neumann G, Kawaoka Y: Orthomyxoviruses. In: Fields Virology. 
Edited by Knipe DM, Howley PM, 5 edn. Phladelphia: Lippincott, Williams, and 
Wilkins; 2007: 1691–1740. 
3. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y: Evolution and 
ecology of influenza A viruses. Microbiol Rev 1992, 56(1):152-179. 
4. Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, Smith D, 
Rimmelzwaan GF, Olsen B, Osterhaus AD: Characterization of a novel 
influenza A virus hemagglutinin subtype (H16) obtained from black-headed 
gulls. J Virol 2005, 79(5):2814-2822. 
5. Oxford JS: Influenza A pandemics of the 20th century with special reference 
to 1918: virology, pathology and epidemiology. Rev Med Virol 2000, 
10(2):119-133. 
6. Taubenberger JK: The origin and virulence of the 1918 "Spanish" influenza 
virus. Proc Am Philos Soc 2006, 150(1):86-112. 
7. Scholtissek C, Rohde W, Von Hoyningen V, Rott R: On the origin of the human 
influenza virus subtypes H2N2 and H3N2. Virology 1978, 87(1):13-20. 
8. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, 
Hernandez M, Miller MA: Severe respiratory disease concurrent with the 
circulation of H1N1 influenza. N Engl J Med 2009, 361(7):674-679. 
9. Lin YP, Gregory V, Bennett M, Hay A: Recent changes among human 
influenza viruses. Virus Res 2004, 103(1-2):47-52. 
10. Lee CW, Saif YM: Avian influenza virus. Comp Immunol Microbiol Infect Dis 
2008. 
11. Korteweg C, Gu J: Pathology, molecular biology, and pathogenesis of avian 
influenza A (H5N1) infection in humans. Am J Pathol 2008, 172(5):1155-1170. 
12. Mumford JA, Chambers TM: Equine influenza. In: Textbook of influenza. Edited 
by Nicholson KG, Webster RG, Hay AJ: Blackwell; 1998: 146-162. 
13. Waddell GH, Teigland MB, Sigel MM: A New Influenza Virus Associated 
With Equine Respiratory Disease. J Am Vet Med Assoc 1963, 143:587-590. 
14. Sovinova O, Tumova B, Pouska F, Nemec J: Isolation of a virus causing 
respiratory disease in horses. Acta Virol 1958, 2(1):52-61. 
15. Beveridge WI, Mahaffey LW, Rose MA: Influenza In Horses. Vet Rec 1965, 
77:57-59. 
16. Doll ER: Influenza of horses. Am Rev Respir Dis 1961, 83(2)Pt 2:48-53. 
17. Tumova B, Easterday BC, Stumpa A: Simultaneous occurrence of A-equi-1 and 
A-equi-2 infleunza viruses in a small group of horses. Am J Epidemiol 1972, 
95(1):80-87. 
18. Gorman OT, Bean WJ, Kawaoka Y, Webster RG: Evolution of the 
nucleoprotein gene of influenza A virus. J Virol 1990, 64(4):1487-1497. 
113 
19. Guo Y, Wang M, Kawaoka Y, Gorman O, Ito T, Saito T, Webster RG: 
Characterization of a new avian-like influenza A virus from horses in China. 
Virology 1992, 188(1):245-255. 
20. Okazaki K, Kawaoka Y, Webster RG: Evolutionary pathways of the PA genes 
of influenza A viruses. Virology 1989, 172(2):601-608. 
21. Bean WJ: Correlation of influenza A virus nucleoprotein genes with host 
species. Virology 1984, 133(2):438-442. 
22. Webster RG: Are equine 1 influenza viruses still present in horses? Equine Vet 
J 1993, 25(6):537-538. 
23. Madic J, Martinovic S, Naglic T, Hajsig D, Cvetnic S: Serological evidence for 
the presence of A/equine-1 influenza virus in unvaccinated horses in Croatia. 
Vet Rec 1996, 138(3):68. 
24. Guo Y, Wang M, Zheng GS, Li WK, Kawaoka Y, Webster RG: 
Seroepidemiological and molecular evidence for the presence of two H3N8 
equine influenza viruses in China in 1993-94. J Gen Virol 1995, 76 ( Pt 
8):2009-2014. 
25. Kilbourne ED, Murphy JS: Genetic studies of influenza viruses. I. Viral 
morphology and growth capacity as exchangeable genetic traits. Rapid in ovo 
adaptation of early passage Asian strain isolates by combination with PR8. J 
Exp Med 1960, 111:387-406. 
26. Choppin PW, Murphy JS, Tamm I: Studies of two kinds of virus particles 
which comprise influenza A2 virus strains. III. Morphological 
characteristics: independence to morphological and functional traits. J Exp 
Med 1960, 112:945-952. 
27. Compans RW, Meier-Ewert H, Palese P: Assembly of lipid-containing viruses. 
J Supramol Struct 1974, 2(2-4):496-511. 
28. Noda T, Sagara H, Yen A, Takada A, Kida H, Cheng RH, Kawaoka Y: 
Architecture of ribonucleoprotein complexes in influenza A virus particles. 
Nature 2006, 439(7075):490-492. 
29. Klenk HD, Rott R, Orlich M, Blodorn J: Activation of influenza A viruses by 
trypsin treatment. Virology 1975, 68(2):426-439. 
30. Weis WI, Brunger AT, Skehel JJ, Wiley DC: Refinement of the influenza virus 
hemagglutinin by simulated annealing. J Mol Biol 1990, 212(4):737-761. 
31. Bosch FX, Garten W, Klenk HD, Rott R: Proteolytic cleavage of influenza virus 
hemagglutinins: primary structure of the connecting peptide between HA1 
and HA2 determines proteolytic cleavability and pathogenicity of Avian 
influenza viruses. Virology 1981, 113(2):725-735. 
32. Stieneke-Grober A, Vey M, Angliker H, Shaw E, Thomas G, Roberts C, Klenk 
HD, Garten W: Influenza virus hemagglutinin with multibasic cleavage site is 
activated by furin, a subtilisin-like endoprotease. Embo J 1992, 11(7):2407-
2414. 
33. Kawaoka Y, Webster RG: Sequence requirements for cleavage activation of 
influenza virus hemagglutinin expressed in mammalian cells. Proc Natl Acad 
Sci U S A 1988, 85(2):324-328. 
34. Webster RG, Rott R: Influenza virus A pathogenicity: the pivotal role of 
hemagglutinin. Cell 1987, 50(5):665-666. 
114 
35. Tamura S, Tanimoto T, Kurata T: Mechanisms of broad cross-protection 
provided by influenza virus infection and their application to vaccines. Jpn J 
Infect Dis 2005, 58(4):195-207. 
36. Luo G, Chung J, Palese P: Alterations of the stalk of the influenza virus 
neuraminidase: deletions and insertions. Virus Res 1993, 29(2):141-153. 
37. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD: 
Neuraminidase is important for the initiation of influenza virus infection in 
human airway epithelium. J Virol 2004, 78(22):12665-12667. 
38. Morris SJ, Price GE, Barnett JM, Hiscox SA, Smith H, Sweet C: Role of 
neuraminidase in influenza virus-induced apoptosis. J Gen Virol 1999, 80 ( Pt 
1):137-146. 
39. Schultz-Cherry S, Hinshaw VS: Influenza virus neuraminidase activates latent 
transforming growth factor beta. J Virol 1996, 70(12):8624-8629. 
40. Noton SL, Medcalf E, Fisher D, Mullin AE, Elton D, Digard P: Identification of 
the domains of the influenza A virus M1 matrix protein required for NP 
binding, oligomerization and incorporation into virions. J Gen Virol 2007, 
88(Pt 8):2280-2290. 
41. Schnell JR, Chou JJ: Structure and mechanism of the M2 proton channel of 
influenza A virus. Nature 2008, 451(7178):591-595. 
42. Portela A, Digard P: The influenza virus nucleoprotein: a multifunctional 
RNA-binding protein pivotal to virus replication. J Gen Virol 2002, 83(Pt 
4):723-734. 
43. Wu WW, Sun YH, Pante N: Nuclear import of influenza A viral 
ribonucleoprotein complexes is mediated by two nuclear localization 
sequences on viral nucleoprotein. Virol J 2007, 4:49. 
44. Berkhoff EG, Geelhoed-Mieras MM, Fouchier RA, Osterhaus AD, Rimmelzwaan 
GF: Assessment of the extent of variation in influenza A virus cytotoxic T-
lymphocyte epitopes by using virus-specific CD8+ T-cell clones. J Gen Virol 
2007, 88(Pt 2):530-535. 
45. Ghanem A, Mayer D, Chase G, Tegge W, Frank R, Kochs G, Garcia-Sastre A, 
Schwemmle M: Peptide-mediated interference with influenza A virus 
polymerase. J Virol 2007, 81(14):7801-7804. 
46. Akkina RK: Antigenic reactivity and electrophoretic migrational 
heterogeneity of the three polymerase proteins of type A human and animal 
influenza viruses. Arch Virol 1990, 111(3-4):187-197. 
47. Blaas D, Patzelt E, Kuechler E: Identification of the cap binding protein of 
influenza virus. Nucleic Acids Res 1982, 10(15):4803-4812. 
48. Ulmanen I, Broni BA, Krug RM: Role of two of the influenza virus core P 
proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in 
initiating viral RNA transcription. Proc Natl Acad Sci U S A 1981, 
78(12):7355-7359. 
49. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, Basta S, O'Neill R, 
Schickli J, Palese P et al: A novel influenza A virus mitochondrial protein that 
induces cell death. Nat Med 2001, 7(12):1306-1312. 
50. Gibbs JS, Malide D, Hornung F, Bennink JR, Yewdell JW: The influenza A 
virus PB1-F2 protein targets the inner mitochondrial membrane via a 
115 
predicted basic amphipathic helix that disrupts mitochondrial function. J 
Virol 2003, 77(13):7214-7224. 
51. Hara K, Schmidt FI, Crow M, Brownlee GG: Amino acid residues in the N-
terminal region of the PA subunit of influenza A virus RNA polymerase play 
a critical role in protein stability, endonuclease activity, cap binding, and 
virion RNA promoter binding. J Virol 2006, 80(16):7789-7798. 
52. Inglis SC, Almond JW: An influenza virus gene encoding two different 
proteins. Philos Trans R Soc Lond B Biol Sci 1980, 288(1029):375-381. 
53. Lazarowitz SG, Compans RW, Choppin PW: Influenza virus structural and 
nonstructural proteins in infected cells and their plasma membranes. 
Virology 1971, 46(3):830-843. 
54. Qiu Y, Nemeroff M, Krug RM: The influenza virus NS1 protein binds to a 
specific region in human U6 snRNA and inhibits U6-U2 and U6-U4 snRNA 
interactions during splicing. Rna 1995, 1(3):304-316. 
55. Fortes P, Beloso A, Ortin J: Influenza virus NS1 protein inhibits pre-mRNA 
splicing and blocks mRNA nucleocytoplasmic transport. Embo J 1994, 
13(3):704-712. 
56. Garfinkel MS, Katze MG: Translational control by influenza virus. Selective 
translation is mediated by sequences within the viral mRNA 5'-untranslated 
region. J Biol Chem 1993, 268(30):22223-22226. 
57. Lu Y, Wambach M, Katze MG, Krug RM: Binding of the influenza virus NS1 
protein to double-stranded RNA inhibits the activation of the protein kinase 
that phosphorylates the elF-2 translation initiation factor. Virology 1995, 
214(1):222-228. 
58. O'Neill RE, Talon J, Palese P: The influenza virus NEP (NS2 protein) mediates 
the nuclear export of viral ribonucleoproteins. Embo J 1998, 17(1):288-296. 
59. Weis W, Brown JH, Cusack S, Paulson JC, Skehel JJ, Wiley DC: Structure of 
the influenza virus haemagglutinin complexed with its receptor, sialic acid. 
Nature 1988, 333(6172):426-431. 
60. White J, Matlin K, Helenius A: Cell fusion by Semliki Forest, influenza, and 
vesicular stomatitis viruses. J Cell Biol 1981, 89(3):674-679. 
61. Sato SB, Kawasaki K, Ohnishi S: Hemolytic activity of influenza virus 
hemagglutinin glycoproteins activated in mildly acidic environments. Proc 
Natl Acad Sci U S A 1983, 80(11):3153-3157. 
62. Pinto LH, Holsinger LJ, Lamb RA: Influenza virus M2 protein has ion channel 
activity. Cell 1992, 69(3):517-528. 
63. Martin K, Helenius A: Transport of incoming influenza virus nucleocapsids 
into the nucleus. J Virol 1991, 65(1):232-244. 
64. Plotch SJ, Bouloy M, Ulmanen I, Krug RM: A unique cap(m7GpppXm)-
dependent influenza virion endonuclease cleaves capped RNAs to generate 
the primers that initiate viral RNA transcription. Cell 1981, 23(3):847-858. 
65. Tiley LS, Hagen M, Matthews JT, Krystal M: Sequence-specific binding of the 
influenza virus RNA polymerase to sequences located at the 5' ends of the 
viral RNAs. J Virol 1994, 68(8):5108-5116. 
116 
66. Hagen M, Chung TD, Butcher JA, Krystal M: Recombinant influenza virus 
polymerase: requirement of both 5' and 3' viral ends for endonuclease 
activity. J Virol 1994, 68(3):1509-1515. 
67. Beaton AR, Krug RM: Transcription antitermination during influenza viral 
template RNA synthesis requires the nucleocapsid protein and the absence of 
a 5' capped end. Proc Natl Acad Sci U S A 1986, 83(17):6282-6286. 
68. Martin K, Helenius A: Nuclear transport of influenza virus 
ribonucleoproteins: the viral matrix protein (M1) promotes export and 
inhibits import. Cell 1991, 67(1):117-130. 
69. Shapiro GI, Krug RM: Influenza virus RNA replication in vitro: synthesis of 
viral template RNAs and virion RNAs in the absence of an added primer. J 
Virol 1988, 62(7):2285-2290. 
70. Leser GP, Lamb RA: Influenza virus assembly and budding in raft-derived 
microdomains: a quantitative analysis of the surface distribution of HA, NA 
and M2 proteins. Virology 2005, 342(2):215-227. 
71. Kundu A, Avalos RT, Sanderson CM, Nayak DP: Transmembrane domain of 
influenza virus neuraminidase, a type II protein, possesses an apical sorting 
signal in polarized MDCK cells. J Virol 1996, 70(9):6508-6515. 
72. Scheiffele P, Roth MG, Simons K: Interaction of influenza virus 
haemagglutinin with sphingolipid-cholesterol membrane domains via its 
transmembrane domain. EMBO J 1997, 16(18):5501-5508. 
73. Chen BJ, Leser GP, Morita E, Lamb RA: Influenza virus hemagglutinin and 
neuraminidase, but not the matrix protein, are required for assembly and 
budding of plasmid-derived virus-like particles. J Virol 2007, 81(13):7111-
7123. 
74. Lai JC, Chan WW, Kien F, Nicholls JM, Peiris JS, Garcia JM: Formation of 
virus-like particles from human cell lines exclusively expressing influenza 
neuraminidase. J Gen Virol 2010, 91(Pt 9):2322-2330. 
75. Ali A, Avalos RT, Ponimaskin E, Nayak DP: Influenza virus assembly: effect of 
influenza virus glycoproteins on the membrane association of M1 protein. J 
Virol 2000, 74(18):8709-8719. 
76. Gomez-Puertas P, Albo C, Perez-Pastrana E, Vivo A, Portela A: Influenza virus 
matrix protein is the major driving force in virus budding. J Virol 2000, 
74(24):11538-11547. 
77. Rossman JS, Jing X, Leser GP, Lamb RA: Influenza virus M2 protein mediates 
ESCRT-independent membrane scission. Cell 2010, 142(6):902-913. 
78. Barman S, Adhikary L, Chakrabarti AK, Bernas C, Kawaoka Y, Nayak DP: Role 
of transmembrane domain and cytoplasmic tail amino acid sequences of 
influenza a virus neuraminidase in raft association and virus budding. J Virol 
2004, 78(10):5258-5269. 
79. Causey D, Edwards SV: Ecology of avian influenza virus in birds. J Infect Dis 
2008, 197 Suppl 1:S29-33. 
80. Alexander DJ: A review of avian influenza in different bird species. Vet 
Microbiol 2000, 74(1-2):3-13. 
81. Swayne DE, Suarez DL: Highly pathogenic avian influenza. Rev Sci Tech 2000, 
19(2):463-482. 
117 
82. Shope R, Lewis P: Swine influenza: experimental transmission and pathology. 
J Exp Med 1931, 54:349-359. 
83. Olsen CW: The emergence of novel swine influenza viruses in North America. 
Virus Res 2002, 85(2):199-210. 
84. Kawaoka Y, Bordwell E, Webster RG: Intestinal replication of influenza A 
viruses in two mammalian species. Brief report. Arch Virol 1987, 93(3-4):303-
308. 
85. Olsen CW, Brown IH, Easterday BC, Van Reeth K: Swine influenza. In: Disease 
of swine. Edited by Straw BE, Zimmerman JJ, d'Allaire S, Taylor DJ: Oxford: 
Blackwell Publishing; 2006: 469-482. 
86. Morley PS, Townsend HG, Bogdan JR, Haines DM: Descriptive epidemiologic 
study of disease associated with influenza virus infections during three 
epidemics in horses. J Am Vet Med Assoc 2000, 216(4):535-544. 
87. Zambon MC: The pathogenesis of influenza in humans. Rev Med Virol 2001, 
11(4):227-241. 
88. Peiris M, Yuen KY, Leung CW, Chan KH, Ip PL, Lai RW, Orr WK, Shortridge 
KF: Human infection with influenza H9N2. Lancet 1999, 354(9182):916-917. 
89. Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat H, Vennema H, 
Meijer A, van Steenbergen J, Fouchier R, Osterhaus A et al: Transmission of 
H7N7 avian influenza A virus to human beings during a large outbreak in 
commercial poultry farms in the Netherlands. Lancet 2004, 363(9409):587-
593. 
90. Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, Chunsuthiwat S, 
Sawanpanyalert P, Kijphati R, Lochindarat S, Srisan P, Suwan P, Osotthanakorn 
Y et al: Human disease from influenza A (H5N1), Thailand, 2004. Emerg 
Infect Dis 2005, 11(2):201-209. 
91. Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, Nguyen VC, Pham TS, 
Vo CD, Le TQ, Ngo TT et al: Avian influenza A (H5N1) in 10 patients in 
Vietnam. N Engl J Med 2004, 350(12):1179-1188. 
92. Oner AF, Bay A, Arslan S, Akdeniz H, Sahin HA, Cesur Y, Epcacan S, Yilmaz 
N, Deger I, Kizilyildiz B et al: Avian influenza A (H5N1) infection in eastern 
Turkey in 2006. N Engl J Med 2006, 355(21):2179-2185. 
93. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, Cheung PT, 
To WK, Ho ET, Sung R et al: Clinical features and rapid viral diagnosis of 
human disease associated with avian influenza A H5N1 virus. Lancet 1998, 
351(9101):467-471. 
94. Uiprasertkul M, Puthavathana P, Sangsiriwut K, Pooruk P, Srisook K, Peiris M, 
Nicholls JM, Chokephaibulkit K, Vanprapar N, Auewarakul P: Influenza A 
H5N1 replication sites in humans. Emerg Infect Dis 2005, 11(7):1036-1041. 
95. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang 
DM, Chau NV, Khanh TH, Dong VC et al: Fatal outcome of human influenza 
A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 
2006, 12(10):1203-1207. 
96. Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM, Ng TK, Chan 
KH, Lai ST, Lim WL et al: Re-emergence of fatal human influenza A subtype 
H5N1 disease. Lancet 2004, 363(9409):617-619. 
118 
97. To KF, Chan PK, Chan KF, Lee WK, Lam WY, Wong KF, Tang NL, Tsang DN, 
Sung RY, Buckley TA et al: Pathology of fatal human infection associated 
with avian influenza A H5N1 virus. J Med Virol 2001, 63(3):242-246. 
98. Chan PK: Outbreak of avian influenza A(H5N1) virus infection in Hong Kong 
in 1997. Clin Infect Dis 2002, 34 Suppl 2:S58-64. 
99. Hirst GK: Studies on the mechanism of adaptation of influenza virus to mice. 
J Exp Med 1947, 86:357-366. 
100. Raut S, Hurd J, Blandford G, Heath RB, Cureton RJ: The pathogenesis of 
infections of the mouse caused by virulent and avirulent variants of an 
influenza virus. J Med Microbiol 1975, 8(1):127-136. 
101. Mori I, Komatsu T, Takeuchi K, Nakakuki K, Sudo M, Kimura Y: Viremia 
induced by influenza virus. Microb Pathog 1995, 19(4):237-244. 
102. francis T, Moore AM: A study of neorotropic tendency in strains of the virus 
of epidemic influenza. J Exp Med 1940, 72:717-728. 
103. Mori I, Kimura Y: Neuropathogenesis of influenza virus infection in mice. 
Microbes Infect 2001, 3(6):475-479. 
104. Wagner RR: A pantropic strain of influenza virus: generalized infection and 
viremia in the infant mouse. Virology 1955, 1(5):497-515. 
105. Garcia-Sastre A, Durbin RK, Zheng H, Palese P, Gertner R, Levy DE, Durbin JE: 
The role of interferon in influenza virus tissue tropism. J Virol 1998, 
72(11):8550-8558. 
106. Belser JA, Lu X, Maines TR, Smith C, Li Y, Donis RO, Katz JM, Tumpey TM: 
Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: 
enhanced virulence of Eurasian H7N7 viruses isolated from humans. J Virol 
2007, 81(20):11139-11147. 
107. Gao P, Watanabe S, Ito T, Goto H, Wells K, McGregor M, Cooley AJ, Kawaoka 
Y: Biological heterogeneity, including systemic replication in mice, of H5N1 
influenza A virus isolates from humans in Hong Kong. J Virol 1999, 
73(4):3184-3189. 
108. Dybing JK, Schultz-Cherry S, Swayne DE, Suarez DL, Perdue ML: Distinct 
pathogenesis of hong kong-origin H5N1 viruses in mice compared to that of 
other highly pathogenic H5 avian influenza viruses. J Virol 2000, 74(3):1443-
1450. 
109. Lu X, Tumpey TM, Morken T, Zaki SR, Cox NJ, Katz JM: A mouse model for 
the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses 
isolated from humans. J Virol 1999, 73(7):5903-5911. 
110. Lipatov AS, Krauss S, Guan Y, Peiris M, Rehg JE, Perez DR, Webster RG: 
Neurovirulence in mice of H5N1 influenza virus genotypes isolated from 
Hong Kong poultry in 2001. J Virol 2003, 77(6):3816-3823. 
111. Tumpey TM, Lu X, Morken T, Zaki SR, Katz JM: Depletion of lymphocytes 
and diminished cytokine production in mice infected with a highly virulent 
influenza A (H5N1) virus isolated from humans. J Virol 2000, 74(13):6105-
6116. 
112. Lu X, Cho D, Hall H, Rowe T, Sung H, Kim W, Kang C, Mo I, Cox N, Klimov A 
et al: Pathogenicity and antigenicity of a new influenza A (H5N1) virus 
isolated from duck meat. J Med Virol 2003, 69(4):553-559. 
119 
113. Szretter KJ, Gangappa S, Lu X, Smith C, Shieh WJ, Zaki SR, Sambhara S, 
Tumpey TM, Katz JM: Role of host cytokine responses in the pathogenesis of 
avian H5N1 influenza viruses in mice. J Virol 2007, 81(6):2736-2744. 
114. Adachi M, Matsukura S, Tokunaga H, Kokubu F: Expression of cytokines on 
human bronchial epithelial cells induced by influenza virus A. Int Arch 
Allergy Immunol 1997, 113(1-3):307-311. 
115. Matsukura S, Kokubu F, Noda H, Tokunaga H, Adachi M: Expression of IL-6, 
IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced 
by influenza virus A. J Allergy Clin Immunol 1996, 98(6 Pt 1):1080-1087. 
116. Sprenger H, Meyer RG, Kaufmann A, Bussfeld D, Rischkowsky E, Gemsa D: 
Selective induction of monocyte and not neutrophil-attracting chemokines 
after influenza A virus infection. J Exp Med 1996, 184(3):1191-1196. 
117. Matikainen S, Pirhonen J, Miettinen M, Lehtonen A, Govenius-Vintola C, 
Sareneva T, Julkunen I: Influenza A and sendai viruses induce differential 
chemokine gene expression and transcription factor activation in human 
macrophages. Virology 2000, 276(1):138-147. 
118. Haller O, Kochs G, Weber F: Interferon, Mx, and viral countermeasures. 
Cytokine Growth Factor Rev 2007, 18(5-6):425-433. 
119. Ada GL, Jones PD: The immune response to influenza infection. Curr Top 
Microbiol Immunol 1986, 128:1-54. 
120. Trinchieri G: Biology of natural killer cells. Adv Immunol 1989, 47:187-376. 
121. Welsh RM: Natural cell-mediated immunity during viral infections. Curr Top 
Microbiol Immunol 1981, 92:83-106. 
122. Beebe DP, Schreiber RD, Cooper NR: Neutralization of influenza virus by 
normal human sera: mechanisms involving antibody and complement. J 
Immunol 1983, 130(3):1317-1322. 
123. Woodland DL, Hogan RJ, Zhong W: Cellular immunity and memory to 
respiratory virus infections. Immunol Res 2001, 24(1):53-67. 
124. Couch RB, Kasel JA: Immunity to influenza in man. Annu Rev Microbiol 1983, 
37:529-549. 
125. Ronni T, Matikainen S, Sareneva T, Melen K, Pirhonen J, Keskinen P, Julkunen 
I: Regulation of IFN-alpha/beta, MxA, 2',5'-oligoadenylate synthetase, and 
HLA gene expression in influenza A-infected human lung epithelial cells. J 
Immunol 1997, 158(5):2363-2374. 
126. Ronni T, Sareneva T, Pirhonen J, Julkunen I: Activation of IFN-alpha, IFN-
gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-
infected human peripheral blood mononuclear cells. J Immunol 1995, 
154(6):2764-2774. 
127. Boehm U, Klamp T, Groot M, Howard JC: Cellular responses to interferon-
gamma. Annu Rev Immunol 1997, 15:749-795. 
128. Platanias LC: Mechanisms of type-I- and type-II-interferon-mediated 
signalling. Nat Rev Immunol 2005, 5(5):375-386. 
129. Levy DE, Garcia-Sastre A: The virus battles: IFN induction of the antiviral 
state and mechanisms of viral evasion. Cytokine Growth Factor Rev 2001, 
12(2-3):143-156. 
120 
130. Lindenmann J: Inheritance Of Resistance To Influenza Virus In Mice. Proc 
Soc Exp Biol Med 1964, 116:506-509. 
131. Horisberger MA, Staeheli P, Haller O: Interferon induces a unique protein in 
mouse cells bearing a gene for resistance to influenza virus. Proc Natl Acad 
Sci U S A 1983, 80(7):1910-1914. 
132. Krug RM, Shaw M, Broni B, Shapiro G, Haller O: Inhibition of influenza viral 
mRNA synthesis in cells expressing the interferon-induced Mx gene product. 
J Virol 1985, 56(1):201-206. 
133. Jin HK, Takada A, Kon Y, Haller O, Watanabe T: Identification of the murine 
Mx2 gene: interferon-induced expression of the Mx2 protein from the feral 
mouse gene confers resistance to vesicular stomatitis virus. J Virol 1999, 
73(6):4925-4930. 
134. Meier E, Kunz G, Haller O, Arnheiter H: Activity of rat Mx proteins against a 
rhabdovirus. J Virol 1990, 64(12):6263-6269. 
135. Staeheli P, Grob R, Meier E, Sutcliffe JG, Haller O: Influenza virus-susceptible 
mice carry Mx genes with a large deletion or a nonsense mutation. Mol Cell 
Biol 1988, 8(10):4518-4523. 
136. Aebi M, Fah J, Hurt N, Samuel CE, Thomis D, Bazzigher L, Pavlovic J, Haller O, 
Staeheli P: cDNA structures and regulation of two interferon-induced human 
Mx proteins. Mol Cell Biol 1989, 9(11):5062-5072. 
137. King MC, Raposo G, Lemmon MA: Inhibition of nuclear import and cell-cycle 
progression by mutated forms of the dynamin-like GTPase MxB. Proc Natl 
Acad Sci U S A 2004, 101(24):8957-8962. 
138. Horisberger MA, Gunst MC: Interferon-induced proteins: identification of Mx 
proteins in various mammalian species. Virology 1991, 180(1):185-190. 
139. Heinz H, Marquardt J, Schuberth HJ, Adolf GR, Leibold W: Proteins induced by 
recombinant equine interferon-beta 1 within equine peripheral blood 
mononuclear cells and polymorphonuclear neutrophilic granulocytes. Vet 
Immunol Immunopathol 1994, 42(3-4):221-235. 
140. Staeheli P, Pitossi F, Pavlovic J: Mx proteins: GTPases with antiviral activity. 
Trends Cell Biol 1993, 3(8):268-272. 
141. Staeheli P, Haller O, Boll W, Lindenmann J, Weissmann C: Mx protein: 
constitutive expression in 3T3 cells transformed with cloned Mx cDNA 
confers selective resistance to influenza virus. Cell 1986, 44(1):147-158. 
142. Pavlovic J, Haller O, Staeheli P: Human and mouse Mx proteins inhibit 
different steps of the influenza virus multiplication cycle. J Virol 1992, 
66(4):2564-2569. 
143. Jin HK, Yoshimatsu K, Takada A, Ogino M, Asano A, Arikawa J, Watanabe T: 
Mouse Mx2 protein inhibits hantavirus but not influenza virus replication. 
Arch Virol 2001, 146(1):41-49. 
144. Sandrock M, Frese M, Haller O, Kochs G: Interferon-induced rat Mx proteins 
confer resistance to Rift Valley fever virus and other arthropod-borne 
viruses. J Interferon Cytokine Res 2001, 21(9):663-668. 
145. Landis H, Simon-Jodicke A, Kloti A, Di Paolo C, Schnorr JJ, Schneider-Schaulies 
S, Hefti HP, Pavlovic J: Human MxA protein confers resistance to Semliki 
Forest virus and inhibits the amplification of a Semliki Forest virus-based 
121 
replicon in the absence of viral structural proteins. J Virol 1998, 72(2):1516-
1522. 
146. Haller O, Frese M, Kochs G: Mx proteins: mediators of innate resistance to 
RNA viruses. Rev Sci Tech 1998, 17(1):220-230. 
147. Chieux V, Chehadeh W, Harvey J, Haller O, Wattre P, Hober D: Inhibition of 
coxsackievirus B4 replication in stably transfected cells expressing human 
MxA protein. Virology 2001, 283(1):84-92. 
148. Gordien E, Rosmorduc O, Peltekian C, Garreau F, Brechot C, Kremsdorf D: 
Inhibition of hepatitis B virus replication by the interferon-inducible MxA 
protein. J Virol 2001, 75(6):2684-2691. 
149. Couch RB, Cate TR, Douglas RG, Jr., Gerone PJ, Knight V: Effect of route of 
inoculation on experimental respiratory viral disease in volunteers and 
evidence for airborne transmission. Bacteriol Rev 1966, 30(3):517-529. 
150. Gong JH, Sprenger H, Hinder F, Bender A, Schmidt A, Horch S, Nain M, Gemsa 
D: Influenza A virus infection of macrophages. Enhanced tumor necrosis 
factor-alpha (TNF-alpha) gene expression and lipopolysaccharide-triggered 
TNF-alpha release. J Immunol 1991, 147(10):3507-3513. 
151. Oh S, McCaffery JM, Eichelberger MC: Dose-dependent changes in influenza 
virus-infected dendritic cells result in increased allogeneic T-cell 
proliferation at low, but not high, doses of virus. J Virol 2000, 74(12):5460-
5469. 
152. Bussfeld D, Kaufmann A, Meyer RG, Gemsa D, Sprenger H: Differential 
mononuclear leukocyte attracting chemokine production after stimulation 
with active and inactivated influenza A virus. Cell Immunol 1998, 186(1):1-7. 
153. Pirhonen J, Matikainen S, Julkunen I: Regulation of virus-induced IL-12 and 
IL-23 expression in human macrophages. J Immunol 2002, 169(10):5673-5678. 
154. Pirhonen J, Sareneva T, Kurimoto M, Julkunen I, Matikainen S: Virus infection 
activates IL-1 beta and IL-18 production in human macrophages by a 
caspase-1-dependent pathway. J Immunol 1999, 162(12):7322-7329. 
155. Cella M, Facchetti F, Lanzavecchia A, Colonna M: Plasmacytoid dendritic cells 
activated by influenza virus and CD40L drive a potent TH1 polarization. Nat 
Immunol 2000, 1(4):305-310. 
156. Coccia EM, Severa M, Giacomini E, Monneron D, Remoli ME, Julkunen I, Cella 
M, Lande R, Uze G: Viral infection and Toll-like receptor agonists induce a 
differential expression of type I and lambda interferons in human 
plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 2004, 
34(3):796-805. 
157. Hao X, Kim TS, Braciale TJ: Differential response of respiratory dendritic cell 
subsets to influenza virus infection. J Virol 2008, 82(10):4908-4919. 
158. Locati M, Murphy PM: Chemokines and chemokine receptors: biology and 
clinical relevance in inflammation and AIDS. Annu Rev Med 1999, 50:425-440. 
159. Kaufmann A, Salentin R, Meyer RG, Bussfeld D, Pauligk C, Fesq H, Hofmann P, 
Nain M, Gemsa D, Sprenger H: Defense against influenza A virus infection: 
essential role of the chemokine system. Immunobiology 2001, 204(5):603-613. 
160. Hartshorn KL, Karnad AB, Tauber AI: Influenza A virus and the neutrophil: a 
model of natural immunity. J Leukoc Biol 1990, 47(2):176-186. 
122 
161. Dinarello CA: Role of interleukin-1 in infectious diseases. Immunol Rev 1992, 
127:119-146. 
162. Vassalli P: The pathophysiology of tumor necrosis factors. Annu Rev Immunol 
1992, 10:411-452. 
163. Dinarello CA, Cannon JG, Mancilla J, Bishai I, Lees J, Coceani F: Interleukin-6 
as an endogenous pyrogen: induction of prostaglandin E2 in brain but not in 
peripheral blood mononuclear cells. Brain Res 1991, 562(2):199-206. 
164. Dinarello CA, Bernheim HA, Duff GW, Le HV, Nagabhushan TL, Hamilton NC, 
Coceani F: Mechanisms of fever induced by recombinant human interferon. J 
Clin Invest 1984, 74(3):906-913. 
165. Wijburg OL, DiNatale S, Vadolas J, van Rooijen N, Strugnell RA: Alveolar 
macrophages regulate the induction of primary cytotoxic T-lymphocyte 
responses during influenza virus infection. J Virol 1997, 71(12):9450-9457. 
166. Monteiro JM, Harvey C, Trinchieri G: Role of interleukin-12 in primary 
influenza virus infection. J Virol 1998, 72(6):4825-4831. 
167. Kawaoka Y: Equine H7N7 influenza A viruses are highly pathogenic in mice 
without adaptation: potential use as an animal model. J Virol 1991, 
65(7):3891-3894. 
168. Banbura MW, Kawaoka Y, Thomas TL, Webster RG: Reassortants with equine 
1 (H7N7) influenza virus hemagglutinin in an avian influenza virus genetic 
background are pathogenic in chickens. Virology 1991, 184(1):469-471. 
169. Gibson CA, Daniels RS, McCauley JW, Schild GC: Hemagglutinin gene 
sequencing studies of equine- 1 influenza A viruses. . In: Equine Infectious 
Diseases. Edited by Powell DG, vol. 5. Lexington: University of Kentucky Press; 
1988: 51-59. 
170. White MR, Doss M, Boland P, Tecle T, Hartshorn KL: Innate immunity to 
influenza virus: implications for future therapy. Expert Rev Clin Immunol 
2008, 4(4):497-514. 
171. Tanaka H, Park CH, Ninomiya A, Ozaki H, Takada A, Umemura T, Kida H: 
Neurotropism of the 1997 Hong Kong H5N1 influenza virus in mice. Vet 
Microbiol 2003, 95(1-2):1-13. 
172. Blaskovic D, Szanto J, Kapitancik B, Lesso J, Lackovic V, Skarda R: 
Experimental pathogenesis of A-equi 1 influenza virus infection in horses. 
Acta Virol 1966, 10(6):513-520. 
173. Blaskovic D, Kapitancik B, Sabo A, Styk B, Vrtiak O, Kaplan M: Experimental 
infection of horses with A-equi 2-Miami-1-63 and human A2-Hong Kong 1-
68 influenza viruses. I. The course of infection and virus recovery. Acta Virol 
1969, 13(6):499-506. 
174. Sutton GA, Viel L, Carman PS, Boag BL: Study of the duration and 
distribution of equine influenza virus subtype 2 (H3N8) antigens in 
experimentally infected ponies in vivo. Can J Vet Res 1997, 61(2):113-120. 
175. Von Magnus P: Propagation of the PR8 strain of influenza A virus in chick 
embryos. III. Properties of the incomplete virus produced in serial passages 
of undiluted virus. Acta Pathol Microbiol Scand 1951, 29(2):157-181. 
123 
176. Davis AR, Hiti AL, Nayak DP: Influenza defective interfering viral RNA is 
formed by internal deletion of genomic RNA. Proc Natl Acad Sci U S A 1980, 
77(1):215-219. 
177. Edlund Toulemonde C, Daly J, Sindle T, Guigal PM, Audonnet JC, Minke JM: 
Efficacy of a recombinant equine influenza vaccine against challenge with an 
American lineage H3N8 influenza virus responsible for the 2003 outbreak in 
the United Kingdom. Vet Rec 2005, 156(12):367-371. 
178. Ramakers C, Ruijter JM, Deprez RH, Moorman AF: Assumption-free analysis 
of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 
2003, 339(1):62-66. 
179. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-
time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 
25(4):402-408. 
180. Breathnach CC, Sturgill-Wright T, Stiltner JL, Adams AA, Lunn DP, Horohov 
DW: Foals are interferon gamma-deficient at birth. Vet Immunol 
Immunopathol 2006, 112(3-4):199-209. 
181. Moore BD, Balasuriya UB, Watson JL, Bosio CM, MacKay RJ, MacLachlan NJ: 
Virulent and avirulent strains of equine arteritis virus induce different 
quantities of TNF-alpha and other proinflammatory cytokines in alveolar 
and blood-derived equine macrophages. Virology 2003, 314(2):662-670. 
182. Yam LT, Li CY, Crosby WH: Cytochemical identification of monocytes and 
granulocytes. Am J Clin Pathol 1971, 55(3):283-290. 
183. Fonteneau JF, Gilliet M, Larsson M, Dasilva I, Munz C, Liu YJ, Bhardwaj N: 
Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for 
plasmacytoid dendritic cells in adaptive immunity. Blood 2003, 101(9):3520-
3526. 
184. Thitithanyanont A, Engering A, Ekchariyawat P, Wiboon-ut S, Limsalakpetch A, 
Yongvanitchit K, Kum-Arb U, Kanchongkittiphon W, Utaisincharoen P, Sirisinha 
S et al: High susceptibility of human dendritic cells to avian influenza H5N1 
virus infection and protection by IFN-alpha and TLR ligands. J Immunol 
2007, 179(8):5220-5227. 
185. Chu VC, Whittaker GR: Influenza virus entry and infection require host cell 
N-linked glycoprotein. Proc Natl Acad Sci U S A 2004, 101(52):18153-18158. 
186. Angata T, Varki A: Chemical diversity in the sialic acids and related alpha-
keto acids: an evolutionary perspective. Chem Rev 2002, 102(2):439-469. 
187. Baum LG, Paulson JC: Sialyloligosaccharides of the respiratory epithelium in 
the selection of human influenza virus receptor specificity. Acta Histochem 
Suppl 1990, 40:35-38. 
188. Suzuki Y, Ito T, Suzuki T, Holland RE, Jr., Chambers TM, Kiso M, Ishida H, 
Kawaoka Y: Sialic acid species as a determinant of the host range of influenza 
A viruses. J Virol 2000, 74(24):11825-11831. 
189. Ibricevic A, Pekosz A, Walter MJ, Newby C, Battaile JT, Brown EG, Holtzman 
MJ, Brody SL: Influenza virus receptor specificity and cell tropism in mouse 
and human airway epithelial cells. J Virol 2006, 80(15):7469-7480. 
124 
190. Rogers GN, Paulson JC: Receptor determinants of human and animal 
influenza virus isolates: differences in receptor specificity of the H3 
hemagglutinin based on species of origin. Virology 1983, 127(2):361-373. 
191. Glaser L, Conenello G, Paulson J, Palese P: Effective replication of human 
influenza viruses in mice lacking a major alpha2,6 sialyltransferase. Virus Res 
2007, 126(1-2):9-18. 
192. Park CH, Ishinaka M, Takada A, Kida H, Kimura T, Ochiai K, Umemura T: The 
invasion routes of neurovirulent A/Hong Kong/483/97 (H5N1) influenza virus 
into the central nervous system after respiratory infection in mice. Arch Virol 
2002, 147(7):1425-1436. 
193. Shinya K, Suto A, Kawakami M, Sakamoto H, Umemura T, Kawaoka Y, Kasai 
N, Ito T: Neurovirulence of H7N7 influenza A virus: brain stem encephalitis 
accompanied with aspiration pneumonia in mice. Arch Virol 2005, 
150(8):1653-1660. 
194. Senne DA, Panigrahy B, Kawaoka Y, Pearson JE, Suss J, Lipkind M, Kida H, 
Webster RG: Survey of the hemagglutinin (HA) cleavage site sequence of H5 
and H7 avian influenza viruses: amino acid sequence at the HA cleavage site 
as a marker of pathogenicity potential. Avian Dis 1996, 40(2):425-437. 
195. Brown EG, Bailly JE: Genetic analysis of mouse-adapted influenza A virus 
identifies roles for the NA, PB1, and PB2 genes in virulence. Virus Res 1999, 
61(1):63-76. 
196. Shinya K, Watanabe S, Ito T, Kasai N, Kawaoka Y: Adaptation of an H7N7 
equine influenza A virus in mice. J Gen Virol 2007, 88(Pt 2):547-553. 
197. Gabriel G, Dauber B, Wolff T, Planz O, Klenk HD, Stech J: The viral 
polymerase mediates adaptation of an avian influenza virus to a mammalian 
host. Proc Natl Acad Sci U S A 2005, 102(51):18590-18595. 
198. Naffakh N, Massin P, Escriou N, Crescenzo-Chaigne B, van der Werf S: Genetic 
analysis of the compatibility between polymerase proteins from human and 
avian strains of influenza A viruses. J Gen Virol 2000, 81(Pt 5):1283-1291. 
199. Wasilenko JL, Lee CW, Sarmento L, Spackman E, Kapczynski DR, Suarez DL, 
Pantin-Jackwood MJ: NP, PB1, and PB2 viral genes contribute to altered 
replication of H5N1 avian influenza viruses in chickens. J Virol 2008, 
82(9):4544-4553. 
200. Hatta M, Gao P, Halfmann P, Kawaoka Y: Molecular basis for high virulence 
of Hong Kong H5N1 influenza A viruses. Science 2001, 293(5536):1840-1842. 
201. Nishimura H, Itamura S, Iwasaki T, Kurata T, Tashiro M: Characterization of 
human influenza A (H5N1) virus infection in mice: neuro-, pneumo- and 
adipotropic infection. J Gen Virol 2000, 81(Pt 10):2503-2510. 
202. Mygind T, Vandahl B, Pedersen AS, Christiansen G, Hollsberg P, Birkelund S: 
Identification of an in vivo CD4+ T cell-mediated response to polymorphic 
membrane proteins of Chlamydia pneumoniae during experimental 
infection. FEMS Immunol Med Microbiol 2004, 40(2):129-137. 
203. Farah CS, Saunus JM, Hu Y, Kazoullis A, Ashman RB: Gene targeting 
demonstrates that inducible nitric oxide synthase is not essential for 
resistance to oral candidiasis in mice, or for killing of Candida albicans by 
macrophages in vitro. Oral Microbiol Immunol 2009, 24(1):83-88. 
125 
204. Nairizi A, She P, Vary TC, Lynch CJ: Leucine supplementation of drinking 
water does not alter susceptibility to diet-induced obesity in mice. J Nutr 
2009, 139(4):715-719. 
205. Avitsur R, Powell N, Padgett DA, Sheridan JF: Social interactions, stress, and 
immunity. Immunol Allergy Clin North Am 2009, 29(2):285-293. 
206. Van Reeth K: Cytokines in the pathogenesis of influenza. Vet Microbiol 2000, 
74(1-2):109-116. 
207. Salomon R, Hoffmann E, Webster RG: Inhibition of the cytokine response does 
not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci U S A 
2007, 104(30):12479-12481. 
208. Hussell T, Pennycook A, Openshaw PJ: Inhibition of tumor necrosis factor 
reduces the severity of virus-specific lung immunopathology. Eur J Immunol 
2001, 31(9):2566-2573. 
209. Belisle SE, Tisoncik JR, Korth MJ, Carter VS, Proll SC, Swayne DE, Pantin-
Jackwood M, Tumpey TM, Katze MG: Genomic profiling of tumor necrosis 
factor alpha (TNF-alpha) receptor and interleukin-1 receptor knockout mice 
reveals a link between TNF-alpha signaling and increased severity of 1918 
pandemic influenza virus infection. J Virol 2010, 84(24):12576-12588. 
210. Julkunen I, Melen K, Nyqvist M, Pirhonen J, Sareneva T, Matikainen S: 
Inflammatory responses in influenza A virus infection. Vaccine 2000, 19 
Suppl 1:S32-37. 
211. Narasaraju T, Ng HH, Phoon MC, Chow VT: MCP-1 Antibody Treatment 
Enhances Damage and Impedes Repair of the Alveolar Epithelium in 
Influenza Pneumonitis. Am J Respir Cell Mol Biol 2010, 42(6):732-743. 
212. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM: H5N1 and 
1918 pandemic influenza virus infection results in early and excessive 
infiltration of macrophages and neutrophils in the lungs of mice. PLoS 
Pathog 2008, 4(8):e1000115. 
213. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Pantin-
Jackwood MJ, Schultz-Cherry S, Solorzano A, Van Rooijen N, Katz JM et al: 
Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: 
functional roles of alveolar macrophages and neutrophils in limiting virus 
replication and mortality in mice. J Virol 2005, 79(23):14933-14944. 
214. Azoulay E, Darmon M, Delclaux C, Fieux F, Bornstain C, Moreau D, Attalah H, 
Le Gall JR, Schlemmer B: Deterioration of previous acute lung injury during 
neutropenia recovery. Crit Care Med 2002, 30(4):781-786. 
215. Graham MB, Dalton DK, Giltinan D, Braciale VL, Stewart TA, Braciale TJ: 
Response to influenza infection in mice with a targeted disruption in the 
interferon gamma gene. J Exp Med 1993, 178(5):1725-1732. 
216. Baumgarth N, Kelso A: In vivo blockade of gamma interferon affects the 
influenza virus-induced humoral and the local cellular immune response in 
lung tissue. J Virol 1996, 70(7):4411-4418. 
217. Nguyen HH, van Ginkel FW, Vu HL, Novak MJ, McGhee JR, Mestecky J: 
Gamma interferon is not required for mucosal cytotoxic T-lymphocyte 
responses or heterosubtypic immunity to influenza A virus infection in mice. 
J Virol 2000, 74(12):5495-5501. 
126 
218. Price GE, Gaszewska-Mastarlarz A, Moskophidis D: The role of alpha/beta and 
gamma interferons in development of immunity to influenza A virus in mice. 
J Virol 2000, 74(9):3996-4003. 
219. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 
10(IL-10) inhibits cytokine synthesis by human monocytes: an 
autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991, 
174(5):1209-1220. 
220. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A: IL-10 inhibits 
cytokine production by activated macrophages. J Immunol 1991, 
147(11):3815-3822. 
221. Evseenko VA, Bukin EK, Zaykovskaya AV, Sharshov KA, Ternovoi VA, 
Ignatyev GM, Shestopalov AM: Experimental infection of H5N1 HPAI in 
BALB/c mice. Virol J 2007, 4:77. 
222. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A: Interleukin-10 and 
the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765. 
223. Kurokawa M, Tsurita M, Brown J, Fukuda Y, Shiraki K: Effect of interleukin-12 
level augmented by Kakkon-to, a herbal medicine, on the early stage of 
influenza infection in mice. Antiviral Res 2002, 56(2):183-188. 
224. Grimm D, Staeheli P, Hufbauer M, Koerner I, Martinez-Sobrido L, Solorzano A, 
Garcia-Sastre A, Haller O, Kochs G: Replication fitness determines high 
virulence of influenza A virus in mice carrying functional Mx1 resistance 
gene. Proc Natl Acad Sci U S A 2007, 104(16):6806-6811. 
225. Xu T, Qiao J, Zhao L, Wang G, He G, Li K, Tian Y, Gao M, Wang J, Wang H et 
al: Acute respiratory distress syndrome induced by avian influenza A (H5N1) 
virus in mice. Am J Respir Crit Care Med 2006, 174(9):1011-1017. 
226. Sumikoshi M, Hashimoto K, Kawasaki Y, Sakuma H, Suzutani T, Suzuki H, 
Hosoya M: Human influenza virus infection and apoptosis induction in 
human vascular endothelial cells. J Med Virol 2008, 80(6):1072-1078. 
227. Zinserling AV, Aksenov OA, Melnikova VF, Zinserling VA: Extrapulmonary 
lesions in influenza. Tohoku J Exp Med 1983, 140(3):259-272. 
228. Ito T, Kobayashi Y, Morita T, Horimoto T, Kawaoka Y: Virulent influenza A 
viruses induce apoptosis in chickens. Virus Res 2002, 84(1-2):27-35. 
229. Muramoto Y, Ozaki H, Takada A, Park CH, Sunden Y, Umemura T, Kawaoka Y, 
Matsuda H, Kida H: Highly pathogenic H5N1 influenza virus causes 
coagulopathy in chickens. Microbiol Immunol 2006, 50(1):73-81. 
230. Perkins LE, Swayne DE: Pathobiology of A/chicken/Hong Kong/220/97 
(H5N1) avian influenza virus in seven gallinaceous species. Vet Pathol 2001, 
38(2):149-164. 
231. Teifke JP, Klopfleisch R, Globig A, Starick E, Hoffmann B, Wolf PU, Beer M, 
Mettenleiter TC, Harder TC: Pathology of natural infections by H5N1 highly 
pathogenic avian influenza virus in mute (Cygnus olor) and whooper 
(Cygnus cygnus) swans. Vet Pathol 2007, 44(2):137-143. 
232. Feldmann A, Schafer MK, Garten W, Klenk HD: Targeted infection of 
endothelial cells by avian influenza virus A/FPV/Rostock/34 (H7N1) in 
chicken embryos. J Virol 2000, 74(17):8018-8027. 
127 
233. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, Lochindarat S, 
Nguyen TK, Nguyen TH, Tran TH et al: Avian influenza A (H5N1) infection in 
humans. N Engl J Med 2005, 353(13):1374-1385. 
234. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, Garcia-
Sastre A, Tolnay AE, Albrecht R, Pyles JA, Olson PH et al: Early and sustained 
innate immune response defines pathology and death in nonhuman primates 
infected by highly pathogenic influenza virus. Proc Natl Acad Sci U S A 2009, 
106(9):3455-3460. 
235. Heltzer ML, Coffin SE, Maurer K, Bagashev A, Zhang Z, Orange JS, Sullivan 
KE: Immune dysregulation in severe influenza. J Leukoc Biol 2009, 
85(6):1036-1043. 
236. van Leuven SI, Franssen R, Kastelein JJ, Levi M, Stroes ES, Tak PP: Systemic 
inflammation as a risk factor for atherothrombosis. Rheumatology (Oxford) 
2008, 47(1):3-7. 
237. Morahan PS, Grossberg SE: Age-related cellular resistance of the chicken 
embryo to viral infections. I. Interferon and natural resistance to 
myxoviruses and vesicular stomatitis virus. J Infect Dis 1970, 121(6):615-623. 
238. Slonim D, Roslerova V, Zavadova H: Pathogenicity of tick-borne encephalitis 
virus for the chicken embryo. IV. Age as a factor of non-specific resistance of 
chicken embryos to the lethal activity of the virus. Acta Virol 1966, 10(2):124-
130. 
239. Zeng H, Goldsmith C, Thawatsupha P, Chittaganpitch M, Waicharoen S, Zaki S, 
Tumpey TM, Katz JM: Highly pathogenic avian influenza H5N1 viruses elicit 
an attenuated type i interferon response in polarized human bronchial 
epithelial cells. J Virol 2007, 81(22):12439-12449. 
240. Marcus PI, Rojek JM, Sekellick MJ: Interferon induction and/or production 
and its suppression by influenza A viruses. J Virol 2005, 79(5):2880-2890. 
241. Seo SH, Hoffmann E, Webster RG: Lethal H5N1 influenza viruses escape host 
anti-viral cytokine responses. Nat Med 2002, 8(9):950-954. 
242. Wattrang E, Jessett DM, Yates P, Fuxler L, Hannant D: Experimental infection 
of ponies with equine influenza A2 (H3N8) virus strains of different 
pathogenicity elicits varying interferon and interleukin-6 responses. Viral 
Immunol 2003, 16(1):57-67. 
243. Riches P, Gooding R, Millar BC, Rowbottom AW: Influence of collection and 
separation of blood samples on plasma IL-1, IL-6 and TNF-alpha 
concentrations. J Immunol Methods 1992, 153(1-2):125-131. 
244. Hartel C, Bein G, Muller-Steinhardt M, Kluter H: Ex vivo induction of cytokine 
mRNA expression in human blood samples. J Immunol Methods 2001, 249(1-
2):63-71. 
245. Feezor RJ, Baker HV, Mindrinos M, Hayden D, Tannahill CL, Brownstein BH, 
Fay A, MacMillan S, Laramie J, Xiao W et al: Whole blood and leukocyte RNA 
isolation for gene expression analyses. Physiol Genomics 2004, 19(3):247-254. 
246. Quinlivan M, Nelly M, Prendergast M, Breathnach C, Horohov D, Arkins S, 
Chiang YW, Chu HJ, Ng T, Cullinane A: Pro-inflammatory and antiviral 
cytokine expression in vaccinated and unvaccinated horses exposed to equine 
influenza virus. Vaccine 2007, 25(41):7056-7064. 
128 
247. van Reeth K, Nauwynck H: Proinflammatory cytokines and viral respiratory 
disease in pigs. Vet Res 2000, 31(2):187-213. 
248. Kaiser L, Fritz RS, Straus SE, Gubareva L, Hayden FG: Symptom pathogenesis 
during acute influenza: interleukin-6 and other cytokine responses. J Med 
Virol 2001, 64(3):262-268. 
249. Gentile DA, Doyle WJ, Fireman P, Skoner DP: Effect of experimental influenza 
A infection on systemic immune and inflammatory parameters in allergic 
and nonallergic adult subjects. Ann Allergy Asthma Immunol 2001, 87(6):496-
500. 
250. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE: Local and 
systemic cytokine responses during experimental human influenza A virus 
infection. Relation to symptom formation and host defense. J Clin Invest 1998, 
101(3):643-649. 
251. Van Reeth K, Labarque G, Nauwynck H, Pensaert M: Differential production of 
proinflammatory cytokines in the pig lung during different respiratory virus 
infections: correlations with pathogenicity. Res Vet Sci 1999, 67(1):47-52. 
252. Barbe F, Atanasova K, Van Reeth K: Cytokines and acute phase proteins 
associated with acute swine influenza infection in pigs. Vet J 2010. 
253. Svitek N, Rudd PA, Obojes K, Pillet S, von Messling V: Severe seasonal 
influenza in ferrets correlates with reduced interferon and increased IL-6 
induction. Virology 2008, 376(1):53-59. 
254. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, 
Leonard EJ: Purification of a human monocyte-derived neutrophil 
chemotactic factor that has peptide sequence similarity to other host defense 
cytokines. Proc Natl Acad Sci U S A 1987, 84(24):9233-9237. 
255. Skoner DP, Gentile DA, Patel A, Doyle WJ: Evidence for cytokine mediation of 
disease expression in adults experimentally infected with influenza A virus. J 
Infect Dis 1999, 180(1):10-14. 
256. Van Reeth K, Van Gucht S, Pensaert M: Correlations between lung 
proinflammatory cytokine levels, virus replication, and disease after swine 
influenza virus challenge of vaccination-immune pigs. Viral Immunol 2002, 
15(4):583-594. 
257. Bazan JF, Timans JC, Kastelein RA: A newly defined interleukin-1? Nature 
1996, 379(6566):591. 
258. Micallef MJ, Ohtsuki T, Kohno K, Tanabe F, Ushio S, Namba M, Tanimoto T, 
Torigoe K, Fujii M, Ikeda M et al: Interferon-gamma-inducing factor enhances 
T helper 1 cytokine production by stimulated human T cells: synergism with 
interleukin-12 for interferon-gamma production. Eur J Immunol 1996, 
26(7):1647-1651. 
259. Zhang T, Kawakami K, Qureshi MH, Okamura H, Kurimoto M, Saito A: 
Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity 
of murine peritoneal exudate cells against Cryptococcus neoformans through 
production of gamma interferon by natural killer cells. Infect Immun 1997, 
65(9):3594-3599. 
260. Puren AJ, Fantuzzi G, Gu Y, Su MS, Dinarello CA: Interleukin-18 (IFNgamma-
inducing factor) induces IL-8 and IL-1beta via TNFalpha production from 
129 
non-CD14+ human blood mononuclear cells. J Clin Invest 1998, 101(3):711-
721. 
261. Liu B, Mori I, Hossain MJ, Dong L, Takeda K, Kimura Y: Interleukin-18 
improves the early defence system against influenza virus infection by 
augmenting natural killer cell-mediated cytotoxicity. J Gen Virol 2004, 85(Pt 
2):423-428. 
262. Denton AE, Doherty PC, Turner SJ, La Gruta NL: IL-18, but not IL-12, is 
required for optimal cytokine production by influenza virus-specific CD8+ T 
cells. Eur J Immunol 2007, 37(2):368-375. 
263. Soboll G, Horohov DW, Aldridge BM, Olsen CW, McGregor MW, Drape RJ, 
Macklin MD, Swain WF, Lunn DP: Regional antibody and cellular immune 
responses to equine influenza virus infection, and particle mediated DNA 
vaccination. Vet Immunol Immunopathol 2003, 94(1-2):47-62. 
264. Breathnach CC, Clark HJ, Clark RC, Olsen CW, Townsend HG, Lunn DP: 
Immunization with recombinant modified vaccinia Ankara (rMVA) 
constructs encoding the HA or NP gene protects ponies from equine 
influenza virus challenge. Vaccine 2006, 24(8):1180-1190. 
265. Day DA, Tuite MF: Post-transcriptional gene regulatory mechanisms in 
eukaryotes: an overview. J Endocrinol 1998, 157(3):361-371. 
266. Horimoto T, Nakayama K, Smeekens SP, Kawaoka Y: Proprotein-processing 
endoproteases PC6 and furin both activate hemagglutinin of virulent avian 
influenza viruses. J Virol 1994, 68(9):6074-6078. 
267. Basak A, Zhong M, Munzer JS, Chretien M, Seidah NG: Implication of the 
proprotein convertases furin, PC5 and PC7 in the cleavage of surface 
glycoproteins of Hong Kong, Ebola and respiratory syncytial viruses: a 
comparative analysis with fluorogenic peptides. Biochem J 2001, 353(Pt 
3):537-545. 
268. Scamuffa N, Calvo F, Chretien M, Seidah NG, Khatib AM: Proprotein 
convertases: lessons from knockouts. FASEB J 2006, 20(12):1954-1963. 
269. Bergeron F, Leduc R, Day R: Subtilase-like pro-protein convertases: from 
molecular specificity to therapeutic applications. J Mol Endocrinol 2000, 
24(1):1-22. 
270. Bahgat MM, Blazejewska P, Schughart K: Inhibition of lung serine proteases in 
mice: a potentially new approach to control influenza infection. Virol J 2011, 
8(1):27. 
271. Wang S, Le TQ, Kurihara N, Chida J, Cisse Y, Yano M, Kido H: Influenza 
virus-cytokine-protease cycle in the pathogenesis of vascular 
hyperpermeability in severe influenza. J Infect Dis 2010, 202(7):991-1001. 
272. Le TQ, Kawachi M, Yamada H, Shiota M, Okumura Y, Kido H: Identification of 
trypsin I as a candidate for influenza A virus and Sendai virus envelope 
glycoprotein processing protease in rat brain. Biol Chem 2006, 387(4):467-
475. 
273. Shpacovitch V, Feld M, Bunnett NW, Steinhoff M: Protease-activated 
receptors: novel PARtners in innate immunity. Trends Immunol 2007, 
28(12):541-550. 
130 
274. Khoufache K, LeBouder F, Morello E, Laurent F, Riffault S, Andrade-Gordon P, 
Boullier S, Rousset P, Vergnolle N, Riteau B: Protective role for protease-
activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-
dependent pathway. J Immunol 2009, 182(12):7795-7802. 
275. Arnheiter H, Skuntz S, Noteborn M, Chang S, Meier E: Transgenic mice with 
intracellular immunity to influenza virus. Cell 1990, 62(1):51-61. 
276. Pavlovic J, Arzet HA, Hefti HP, Frese M, Rost D, Ernst B, Kolb E, Staeheli P, 
Haller O: Enhanced virus resistance of transgenic mice expressing the human 
MxA protein. J Virol 1995, 69(7):4506-4510. 
277. Salomon R, Staeheli P, Kochs G, Yen HL, Franks J, Rehg JE, Webster RG, 
Hoffmann E: Mx1 gene protects mice against the highly lethal human H5N1 
influenza virus. Cell Cycle 2007, 6(19):2417-2421. 
278. Tumpey TM, Szretter KJ, Van Hoeven N, Katz JM, Kochs G, Haller O, Garcia-
Sastre A, Staeheli P: The Mx1 gene protects mice against the pandemic 1918 
and highly lethal human H5N1 influenza viruses. J Virol 2007, 81(19):10818-
10821. 
279. Bazzigher L, Schwarz A, Staeheli P: No enhanced influenza virus resistance of 
murine and avian cells expressing cloned duck Mx protein. Virology 1993, 
195(1):100-112. 
280. Seyama T, Ko JH, Ohe M, Sasaoka N, Okada A, Gomi H, Yoneda A, Ueda J, 
Nishibori M, Okamoto S et al: Population research of genetic polymorphism at 
amino acid position 631 in chicken Mx protein with differential antiviral 
activity. Biochem Genet 2006, 44(9-10):437-448. 
281. Daviet S, Van Borm S, Habyarimana A, Ahanda ML, Morin V, Oudin A, Van 
Den Berg T, Zoorob R: Induction of Mx and PKR failed to protect chickens 
from H5N1 infection. Viral Immunol 2009, 22(6):467-472. 
282. Zhou A, Paranjape JM, Der SD, Williams BR, Silverman RH: Interferon action 
in triply deficient mice reveals the existence of alternative antiviral pathways. 
Virology 1999, 258(2):435-440. 
283. Randall RE, Goodbourn S: Interferons and viruses: an interplay between 
induction, signalling, antiviral responses and virus countermeasures. J Gen 
Virol 2008, 89(Pt 1):1-47. 
284. van Der Meulen KM, Nauwynck HJ, Buddaert W, Pensaert MB: Replication of 
equine herpesvirus type 1 in freshly isolated equine peripheral blood 
mononuclear cells and changes in susceptibility following mitogen 
stimulation. J Gen Virol 2000, 81(Pt 1):21-25. 
285. Denman AM, Rager-Zisman B, Merigan TC, Tyrrell DA: Replication or 
inactivation of different viruses by human lymphocyte preparations. Infect 
Immun 1974, 9(2):373-376. 
286. Dwyer JM, Mackay IR: Antigen-binding lymphocytes in human blood. Lancet 
1970, 1(7639):164-167. 
287. Brownson JM, Mahy BW, Hazleman BL: Interaction of influenza A virus with 
human peripheral blood lymphocytes. Infect Immun 1979, 25(2):749-756. 
288. Raabe MR, Issel CJ, Montelaro RC: Equine monocyte-derived macrophage 
cultures and their applications for infectivity and neutralization studies of 
equine infectious anemia virus. J Virol Methods 1998, 71(1):87-104. 
131 
289. Maury W: Monocyte maturation controls expression of equine infectious 
anemia virus. J Virol 1994, 68(10):6270-6279. 
290. Jelachich ML, Bramlage C, Lipton HL: Differentiation of M1 myeloid 
precursor cells into macrophages results in binding and infection by 
Theiler's murine encephalomyelitis virus and apoptosis. J Virol 1999, 
73(4):3227-3235. 
291. Gordon S: Macrophage-restricted molecules: role in differentiation and 
activation. Immunol Lett 1999, 65(1-2):5-8. 
292. Resnick-Roguel N, Burstein H, Hamburger J, Panet A, Eldor A, Vlodavsky I, 
Kotler M: Cytocidal effect caused by the envelope glycoprotein of a newly 
isolated avian hemangioma-inducing retrovirus. J Virol 1989, 63(10):4325-
4330. 
293. Tsung K, Yim JH, Marti W, Buller RM, Norton JA: Gene expression and 
cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV 
light. J Virol 1996, 70(1):165-171. 
294. Lowy RJ, Dimitrov DS: Characterization of influenza virus-induced death of 
J774.1 macrophages. Exp Cell Res 1997, 234(2):249-258. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
132 
VITA 
 
Liang Zhang was born in Dandong, China on June 05, 1975.  
 
 
 
 
 
 
 
 
 
 
 
 
